Exhibit (d)(6)
EXECUTION VERSION
SECOND
SUPPLEMENTAL INDENTURE
between
TRIPLEPOINT VENTURE GROWTH BDC CORP.
and
U.S. BANK NATIONAL
ASSOCIATION,
as Trustee
Dated as of July 14, 2017
THIS SECOND SUPPLEMENTAL INDENTURE (this “Second Supplemental Indenture”), dated as of July 14, 2017, is between TriplePoint
Venture Growth BDC Corp., a Maryland corporation (the “Company”), and U.S. Bank National Association, as trustee (the “Trustee”). All capitalized terms used herein shall have the meaning set forth in the Base Indenture (as
defined below).
RECITALS OF THE COMPANY
The Company and the Trustee executed and delivered an Indenture, dated as of July 31, 2015 (the “Base Indenture” and, as
supplemented by this Second Supplemental Indenture, the “Indenture”), to provide for the issuance by the Company from time to time of the Company’s unsecured debentures, notes or other evidences of indebtedness (the
“Securities”), to be issued in one or more series as provided in the Indenture.
The Company desires to issue and sell up to
$65,000,000 aggregate principal amount (or up to $74,750,000 aggregate principal amount if the underwriters’ option to purchase additional Notes is exercised in full) of the Company’s 5.75% Notes due 2022 (the “Notes”).
The Company previously entered into the First Supplemental Indenture, dated as of August 4, 2015 (the “First Supplemental
Indenture”), which amended and supplemented the Base Indenture. The First Supplemental Indenture is not applicable to the Notes.
Sections 9.01(4) and 9.01(6) of the Base Indenture provide that without the consent of Holders of the Securities of any series issued
under the Indenture, the Company, when authorized by or pursuant to a Board Resolution, and the Trustee, at any time and from time to time, may enter into one or more indentures supplemental to the Base Indenture to (i) change or eliminate any
of the provisions of the Indenture when there is no Security Outstanding of any series created prior to the execution of the supplemental indenture that is entitled to the benefit of such provision and (ii) establish the form or terms of
Securities of any series as permitted by Section 2.01 and Section 3.01 of the Base Indenture.
The Company desires to establish the form and terms of the Notes and to modify, alter, supplement
and change certain provisions of the Base Indenture for the benefit of the Holders of the Notes (except as may be provided in a future supplemental indenture to the Indenture (a “Future Supplemental Indenture”)).
The Company has duly authorized the execution and delivery of this Second Supplemental Indenture to provide for the issuance of the Notes and
all acts and things necessary to make this Second Supplemental Indenture a valid, binding, and legal obligation of the Company and to constitute a valid agreement of the Company, in accordance with its terms, have been done and performed.
NOW, THEREFORE, for and in consideration of the premises and the purchase of the Notes by the Holders thereof, it is mutually agreed, for the
equal and proportionate benefit of all Holders of the Notes, as follows:
ARTICLE I
TERMS OF THE NOTES
Section 1.01.
Terms of the Notes
. The following terms relating to the Notes are hereby established:
(a) The Notes shall constitute a series of Senior Securities having the title “5.75% Notes due 2022.” The Notes shall bear a CUSIP
number of 89677Y 308 and an ISIN number of US89677Y3080.
(b) The aggregate principal amount of the Notes that may be initially
authenticated and delivered under the Indenture (except for Notes authenticated and delivered upon registration of, transfer of, or in exchange for, or in lieu of, other Notes pursuant to Sections 3.04, 3.05, 3.06, 9.06, 11.07 or 13.05 of the
Base Indenture, and except for any Securities that, pursuant to Section 3.03 of the Base Indenture, are deemed never to have been authenticated and delivered under the Indenture) shall be $65,000,000 (or up to $74,750,000 aggregate principal
amount if the underwriters’ option to purchase additional Notes is exercised in full). Under a Board Resolution, Officers’ Certificate pursuant to Board Resolutions or an indenture supplement, the Company may from time to time, without the
consent of the Holders of Notes, issue additional Notes (in any such case “Additional Notes”) having the same ranking and the same interest rate, maturity and other terms as the Notes. Any Additional Notes and the existing Notes will
constitute a single series under the Indenture and all references to the relevant Notes herein shall include the Additional Notes unless the context otherwise requires.
(c) The entire outstanding principal of the Notes shall be payable on July 15, 2022.
(d) The rate at which the Notes shall bear interest shall be 5.75% per annum (the “Applicable Interest Rate”). The date from
which interest shall accrue on the Notes shall be July 14, 2017, or the most recent Interest Payment Date to which interest has been paid or provided for; the Interest Payment Dates for the Notes shall be January 15, April 15,
July 15 and October 15 of each year, commencing October 15, 2017 (if an Interest Payment Date falls on a
2
day that is not a Business Day, then the applicable interest payment will be made on the next succeeding Business Day and no additional interest will accrue as a result of such delayed payment);
the initial interest period will be the period from and including July 14, 2017, to, but excluding, the initial Interest Payment Date, and the subsequent interest periods will be the periods from and including an Interest Payment Date to, but
excluding, the next Interest Payment Date or the Stated Maturity, as the case may be; the interest so payable, and punctually paid or duly provided for, on any Interest Payment Date, will be paid to the Person in whose name the Note (or one or more
Predecessor Securities) is registered at the close of business on the Regular Record Date for such interest, which shall be January 1, April 1, July 1 and October 1 (whether or not a Business Day), as the case may be, next
preceding such Interest Payment Date. Payment of principal of (and premium, if any, on) and any such interest on the Notes will be made at the office of the Trustee located at 111 Fillmore Avenue East Street, St. Paul, MN 55107, Attention:
TriplePoint Venture Growth BDC Corp. (5.75% Notes Due 2022) and at such other address as designated by the Trustee, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private
debts;
provided
,
however
, that at the option of the Company payment of interest may be made by wire transfer or check mailed to the address of the Person entitled thereto as such address shall appear in the Security Register;
provided
,
further
,
however
, that so long as the Notes are registered to Cede & Co., such payment will be made by wire transfer in accordance with the procedures established by The Depository Trust Company and the
Trustee. Interest on the Notes will be computed on the basis of a 360-day year of twelve 30-day months.
(e) The Notes shall be initially
issuable in global form (each such Note, a “Global Note”). The Global Notes and the Trustee’s certificate of authentication thereon shall be substantially in the form of Exhibit A to this Second Supplemental Indenture. Each Global
Note shall represent the outstanding Notes as shall be specified therein and each shall provide that it shall represent the aggregate amount of outstanding Notes from time to time endorsed thereon and that the aggregate amount of outstanding Notes
represented thereby may from time to time be reduced or increased, as appropriate, to reflect exchanges and redemptions. Any endorsement of a Global Note to reflect the amount of any increase or decrease in the amount of outstanding Notes
represented thereby shall be made by the Trustee or the Security Registrar, in accordance with Sections 2.03 and 3.05 of the Base Indenture.
(f) The depositary for such Global Notes (the “Depositary”) shall be The Depository Trust Company, New York, New York. The Security
Registrar with respect to the Global Notes shall be the Trustee.
(g) The Notes shall be defeasible pursuant to Section 14.02 or
Section 14.03 of the Base Indenture. Covenant defeasance contained in Section 14.03 of the Base Indenture shall apply to the covenants contained in Sections 10.07 and 10.08 of the Indenture.
(h) The Notes shall be redeemable pursuant to Section 11.01 of the Base Indenture and as follows:
(i) The Notes will be redeemable in whole or in part at any time or from time to time, at the option of the Company, on or after July 15,
2019, at a redemption price equal to 100% of the outstanding principal amount thereof, plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to, but excluding, the date fixed for
redemption.
3
(ii) Notice of redemption shall be given in writing and mailed, first-class postage prepaid or
by overnight courier guaranteeing next-day delivery, to each Holder of the Notes to be redeemed, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date, at the Holder’s address appearing in the Security
Register. All notices of redemption shall contain the information set forth in Section 11.04 of the Base Indenture.
(iii) Any
exercise of the Company’s option to redeem the Notes will be done in compliance with the Investment Company Act, to the extent applicable.
(iv) If the Company elects to redeem only a portion of the Notes, the Trustee or, with respect to the Global Notes, the Depositary will
determine the method for selecting the particular Notes to be redeemed, in accordance with Section 11.03 of the Base Indenture and the Investment Company Act and the rules of any national securities exchange or quotation system on which the
Notes are listed, in each case to the extent applicable.
(v) Unless the Company defaults in payment of the Redemption Price, on and after
the Redemption Date, interest will cease to accrue on the Notes called for redemption hereunder.
(i) The Notes shall not be subject to any
sinking fund pursuant to Section 12.01 of the Base Indenture.
(j) The Notes shall be issuable in denominations of $25 and integral
multiples of $25 in excess thereof.
(k) Holders of the Notes will not have the option to have the Notes repaid prior to the Stated
Maturity.
(l) The Notes are hereby designated as “Senior Securities” under the Indenture.
ARTICLE II
DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION
Section 2.01.
Except as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the Notes but no
other series of Securities under the Indenture, whether now or hereafter issued and Outstanding, Article I of the Base Indenture shall be amended by adding the following defined terms to Section 1.01 in appropriate alphabetical sequence,
as follows:
“‘
Exchange Act
’ means the Securities Exchange Act of 1934, as amended, and any statute successor
thereto.”
“‘
GAAP
’ means generally accepted accounting principles in the United States set forth in the
opinions and pronouncements of the Accounting Principles Board of the American Institute
4
of Certified Public Accountants, the opinions and pronouncements of the Public Company Accounting Oversight Board and the statements and pronouncements of the Financial Accounting Standards Board
or in such other statements by such other entity as have been approved by a significant segment of the accounting profession in the United States, which are in effect from time to time.”
“‘
Investment Company Act
’ means the Investment Company act of 1940, as amended, and the rules, regulations and
interpretations promulgated thereunder, to the extent applicable, and any statute successor thereto.”
ARTICLE III
REMEDIES
Section 3.01.
Except as provided in a Future Supplemental Indenture, for the benefit of the Holders of the Notes but no other
series of Securities under the Indenture, whether now or hereafter issued and Outstanding, Section 5.01 of the Base Indenture shall be amended by replacing clauses (2) and (6) thereof with the following:
“(2) default in the payment of the principal of (or premium, if any, on) any Security of that series when it becomes due and payable at
its Maturity;”
“(6) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that:
(A) is for relief against the Company in an involuntary case or proceeding, or
(B) adjudges the Company bankrupt or insolvent, or approves as properly filed a petition seeking reorganization, arrangement,
adjustment or composition of or in respect of the Company, or
(C) appoints a Custodian of the Company or for all or
substantially all of its property, or
(D) orders the winding up or liquidation of the Company,
and the continuance of any such decree or order for relief or any such other decree or order unstayed and in effect for a period of 60 consecutive days;
or”.
ARTICLE IV
COVENANTS
Section 4.01.
Except as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the Notes but no
other series of Securities under the Indenture, whether now or hereafter issued and Outstanding, Article X of the Base Indenture shall be amended by adding the following new Sections 10.07, 10.08 and 10.09 thereto, each as set forth below:
5
“Section 10.07.
Section 18(a)(1)(A) of the Investment Company Act
.
The Company hereby agrees that for the period of time during which Notes are Outstanding, the Company will not violate
Section 18(a)(1)(A) as modified by Section 61(a)(1) of the Investment Company Act or any successor provisions thereto of the Investment Company Act, whether or not the Company continues to be subject to such provisions of the Investment
Company Act, but giving effect, in either case, to any exemptive relief granted to the Company by the Commission.”
“Section 10.08.
Section 18(a)(1)(B) of the Investment Company Act
.
The Company hereby agrees that for the period of time during which Notes are Outstanding, the Company will not violate
Section 18(a)(1)(B) as modified by Section 61(a)(1) of the Investment Company Act or any successor provisions thereto of the Investment Company Act, whether or not the Company is subject to such provisions of the Investment Company Act,
and after giving effect to any exemptive relief granted to the Company by the Commission, except that the Company may declare a cash dividend or distribution, notwithstanding the prohibition contained in Section 18(a)(1)(B) as modified by
Section 61(a)(1) of the Investment Company Act, but only up to such amount as is necessary in order for the Company to maintain its status as a regulated investment company under Subchapter M of the Internal Revenue Code of 1986; provided,
however, that the prohibition in this Section 10.08 shall not apply until such time as the Company’s asset coverage has been below the minimum asset coverage required pursuant to Section 18(a)(1)(B) as modified by
Section 61(a)(1) of the Investment Company Act or any successor provisions thereto of the Investment Company Act (after giving effect to any exemptive relief granted to the Company by the Commission) for more than six (6) consecutive
months.”
“Section 10.09.
Commission Reports and Reports to Holders
.
If, at any time, the Company is not subject to the reporting requirements of Sections 13 or 15(d) of the Exchange Act to file any
periodic reports with the Commission, the Company agrees to furnish to the Holders of Notes and the Trustee for the period of time during which the Notes are Outstanding: (i) within 90 days after the end of the each fiscal year of the
Company (which fiscal year ends on December 31), audited annual consolidated financial statements of the Company and (ii) within 45 days after the end of each fiscal quarter of the Company (other than the Company’s fourth fiscal
quarter), unaudited interim consolidated financial statements of the Company. All such financial statements shall be prepared, in all material respects, in accordance with GAAP.”
ARTICLE V
REDEMPTION OF SECURITIES
Section 5.01.
Except as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the Notes but no
other series of Securities under the Indenture, whether now or hereafter issued and Outstanding, Section 11.03 of the Base Indenture shall be amended by replacing the first paragraph thereof with the following:
“If less than all the Securities of any series issued on the same day with the same terms are to be redeemed, the
particular Securities to be redeemed shall be selected not
6
more than 60 days prior to the Redemption Date by the Trustee, or by the Depositary in the case of global Securities, in compliance with the requirements of DTC, from the Outstanding
Securities of such series issued on such date with the same terms not previously called for redemption, in compliance with the requirements of the principal national securities exchange on which the Securities are listed (if the Securities are
listed on any national securities exchange), or if the Securities are not held through DTC or listed on any national securities exchange, or DTC prescribed no method of selection, on a pro rata basis, or by such method as the Trustee shall deem
fair and appropriate and subject to and otherwise in accordance with the procedures of the applicable Depositary; provided that such method complies with the rules of any national securities exchange or quotation system on which the Securities are
listed, and may provide for the selection for redemption of portions (equal to the minimum authorized denomination for Securities of that series or any integral multiple thereof) of the principal amount of Securities of such series of a denomination
larger than the minimum authorized denomination for Securities of that series; provided, however, that no such partial redemption shall reduce the portion of the principal amount of a Security not redeemed to less than the minimum authorized
denomination for Securities of such series.”
ARTICLE VI
MEETINGS OF HOLDERS OF SECURITIES
Section 6.01.
Except as may be provided in a Future Supplemental Indenture, for the benefit of the Holders of the Notes but no
other series of Securities under the Indenture, whether now or hereafter issued and Outstanding, Section 15.05 of the Base Indenture shall be amended by replacing clause (c) thereof with the following:
“(c) At any meeting of Holders, each Holder of a Security of such series or proxy shall be entitled to one vote for each
$25.00 principal amount of the Outstanding Securities of such series held or represented by such Holder; provided, however, that no vote shall be cast or counted at any meeting in respect of any Security challenged as not Outstanding and ruled by
the chairman of the meeting to be not Outstanding. The chairman of the meeting shall have no right to vote, except as a Holder of a Security of such series or proxy.”
ARTICLE VII
MISCELLANEOUS
Section 7.01.
This Second Supplemental Indenture and the Notes shall be governed by and construed in accordance with the law of
the State of New York, without regard to principles of conflicts of laws. This Second Supplemental Indenture is subject to the provisions of the Trust Indenture Act that are required to be part of the Indenture and shall, to the extent applicable,
be governed by such provisions.
Section 7.02.
In case any provision in this Second Supplemental Indenture or in the Notes
shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.
7
Section 7.03.
This Second Supplemental Indenture may be executed in counterparts,
each of which will be an original, but such counterparts will together constitute but one and the same Second Supplemental Indenture. The exchange of copies of this Second Supplemental Indenture and of signature pages by facsimile, .pdf
transmission, email or other electronic means shall constitute effective execution and delivery of this Second Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile, .pdf transmission, email or other
electronic means shall be deemed to be their original signatures for all purposes.
Section 7.04.
The Base Indenture, as
supplemented and amended by this Second Supplemental Indenture, is in all respects ratified and confirmed, and the Base Indenture and this Second Supplemental Indenture shall be read, taken and construed as one and the same instrument with respect
to the Notes. All provisions included in this Second Supplemental Indenture supersede any conflicting provisions included in the Base Indenture with respect to the Notes, unless not permitted by law. The Trustee accepts the trusts created by the
Base Indenture, as supplemented by this Second Supplemental Indenture, and agrees to perform the same upon the terms and conditions of the Base Indenture, as supplemented by this Second Supplemental Indenture.
Section 7.05.
The provisions of this Second Supplemental Indenture shall become effective as of the date hereof.
Section 7.06.
Notwithstanding anything else to the contrary herein, the terms and provisions of this Second Supplemental Indenture
shall apply only to the Notes and shall not apply to any other series of Securities under the Indenture and this Second Supplemental Indenture shall not and does not otherwise affect, modify, alter, supplement or change the terms and provisions of
any other series of Securities under the Indenture, whether now or hereafter issued and Outstanding.
Section 7.07.
The
recitals contained herein and in the Notes shall be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness. The Trustee makes no representations as to the validity or sufficiency of this Second
Supplemental Indenture, the Notes or any Additional Notes, except that the Trustee represents that it is duly authorized to execute and deliver this Second Supplemental Indenture, authenticate the Notes and any Additional Notes and perform its
obligations hereunder. The Trustee shall not be accountable for the use or application by the Company of the Notes or any Additional Notes or the proceeds thereof.
8
IN WITNESS WHEREOF, the parties hereto have caused this Second Supplemental Indenture to be duly
executed as of the date first above written.
|
|
|
|
|
|
|
TRIPLEPOINT VENTURE GROWTH BDC CORP.
|
|
|
|
|
By:
|
|
/s/ Sajal K. Srivastava
|
|
|
|
Name:
|
|
Sajal K. Srivastava
|
|
|
|
Title:
|
|
President and Secretary
|
|
|
|
U.S. BANK NATIONAL ASSOCIATION,
as Trustee
|
|
|
|
|
By:
|
|
/s/ Karen R. Beard
|
|
|
|
Name:
|
|
Karen R. Beard
|
|
|
|
Title:
|
|
Vice President
|
[
Signature page to Second Supplemental Indenture
]
Exhibit A – Form of Global Note
This Security is a Global Note within the meaning of the Indenture hereinafter referred to and is registered in the name of The Depository Trust Company or a
nominee thereof. This Security may not be exchanged in whole or in part for a Security registered, and no transfer of this Security in whole or in part may be registered, in the name of any Person other than The Depository Trust Company or a nominee
thereof, except in the limited circumstances described in the Indenture.
Unless this certificate is presented by an authorized representative of The
Depository Trust Company to the issuer or its agent for registration of transfer, exchange or payment and such certificate issued in exchange for this certificate is registered in the name of Cede & Co., or such other name as requested by
an authorized representative of The Depository Trust Company, any transfer, pledge or other use hereof for value or otherwise by or to any person is wrongful, as the registered owner hereof, Cede & Co., has an interest herein.
TriplePoint Venture Growth BDC Corp.
|
|
|
|
|
No.
|
|
$
|
|
|
|
CUSIP No. 89677Y 308
|
|
|
|
ISIN No. US89677Y3080
|
5.75% Notes due 2022
TriplePoint Venture Growth BDC Corp., a corporation duly organized and existing under the laws of Maryland (herein called the
“Company,” which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to Cede & Co., or registered assigns, the principal sum of
(U.S. $ ) on July 15, 2022 and to pay interest
thereon from July 14, 2017 or from the most recent Interest Payment Date to which interest has been paid or duly provided for, quarterly on January 15, April 15, July 15 and October 15 in each year, commencing
October 15, 2017, at the rate of 5.75% per annum, until the principal hereof is paid or made available for payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in such
Indenture, be paid to the Person in whose name this Security is registered at the close of business on the Regular Record Date for such interest, which shall be January 1, April 1, July 1 and October 1 (whether or not a Business
Day), as the case may be, next preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in
whose name this Security is registered at the close of business on a Special Record Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice whereof shall be given to Holders of Securities of this series not less than
10 days prior to such Special Record Date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of this series may be listed, and upon such notice as may be
required by such exchange, all as more fully provided in said Indenture. This Security may be issued as part of a series.
Exhibit
A – 1
Payment of the principal of (and premium, if any, on) and any such interest on this Security will
be made at the office of the Trustee located at 111 Fillmore Avenue East Street, St. Paul, MN 55107, Attention: TriplePoint Venture Growth BDC Corp. (5.75% Notes Due 2022) and at such other address as designated by the Trustee, in such coin or
currency of the United States of America as at the time of payment is legal tender for payment of public and private debts; provided, however, that at the option of the Company payment of interest may be made by wire transfer or check mailed to the
address of the Person entitled thereto as such address shall appear in the Security Register;
provided, further, however
, that so long as this Security is registered to Cede & Co., such payment will be made by wire transfer in
accordance with the procedures established by The Depository Trust Company and the Trustee.
Reference is hereby made to the further
provisions of this Security set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place.
Unless the certificate of authentication hereon has been executed by the Trustee referred to on the reverse hereof by manual signature, this
Security shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.
Exhibit
A – 2
IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed.
Dated:
|
|
|
|
|
TRIPLEPOINT VENTURE GROWTH BDC CORP.
|
Attest
Exhibit
A – 3
This is one of the Securities of the series designated therein referred to in the
within-mentioned Indenture.
Dated:
|
|
|
|
|
U.S. BANK NATIONAL ASSOCIATION, as Trustee
|
|
|
|
|
By:
|
|
|
|
|
|
Authorized Signatory
|
Exhibit
A – 4
TriplePoint Venture Growth BDC Corp.
5.75% Notes due 2022
This
Security is one of a duly authorized issue of Senior Securities of the Company (herein called the “Securities”), issued and to be issued in one or more series under an Indenture, dated as of July 31, 2015 (herein called the “Base
Indenture”, which term shall have the meaning assigned to it in such instrument), between the Company and U.S. Bank National Association, as Trustee (herein called the “Trustee”, which term includes any successor trustee under the
Base Indenture), and reference is hereby made to the Base Indenture for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee, and the Holders of the Securities and of the terms
upon which the Securities are, and are to be, authenticated and delivered, as supplemented by the Second Supplemental Indenture relating to the Securities, dated July 14, 2017, by and between the Company and the Trustee (herein called the
“Second Supplemental Indenture”, the Second Supplemental Indenture and the Base Indenture collectively are herein called the “Indenture”). In the event of any conflict between the Base Indenture and the Second Supplemental
Indenture, the Second Supplemental Indenture shall govern and control.
This Security is one of the series designated on the face hereof,
which series is initially limited in aggregate principal amount to $ (or up to $ aggregate principal
amount if the underwriters’ option to purchase additional Securities is exercised in full). Under a Board Resolution, Officers’ Certificate pursuant to Board Resolutions or an indenture supplement, the Company may from time to time,
without the consent of the Holders of Securities, issue additional Securities of this series (in any such case “Additional Securities”) having the same ranking and the same interest rate, maturity and other terms as the Securities. Any
Additional Securities and the existing Securities will constitute a single series under the Indenture and all references to the relevant Securities herein shall include the Additional Securities unless the context otherwise requires. The aggregate
amount of outstanding Securities represented hereby may from time to time be reduced or increased, as appropriate, to reflect exchanges and redemptions.
The Securities of this series are subject to redemption in whole or in part at any time or from time to time, at the option of the Company, on
or after July 15, 2019, at a redemption price per security equal to 100% of the outstanding principal amount thereof plus accrued and unpaid interest payments otherwise payable for the then-current quarterly interest period accrued to the date
fixed for redemption.
Notice of redemption shall be given in writing and mailed, first-class postage prepaid or by overnight courier
guaranteeing next-day delivery, to each Holder of the Securities to be redeemed, not less than thirty (30) nor more than sixty (60) days prior to the Redemption Date, at the Holder’s address appearing in the Security Register. All
notices of redemption shall contain the information set forth in Section 11.04 of the Base Indenture.
Any exercise of the
Company’s option to redeem the Securities will be done in compliance with the Investment Company Act, to the extent applicable.
1
If the Company elects to redeem only a portion of the Securities, the Trustee or, with respect to
global Securities, the Depositary will determine the method for selecting the particular Securities to be redeemed, in accordance with Section 1.01 of the Second Supplemental Indenture and Section 11.03 of the Base Indenture. In the event
of redemption of this Security in part only, a new Security or Securities of this series and of like tenor for the unredeemed portion hereof will be issued in the name of the Holder hereof upon the cancellation hereof.
Unless the Company defaults in payment of the Redemption Price, on and after the Redemption Date, interest will cease to accrue on the Notes
called for redemption.
Holders of Securities do not have the option to have the Securities repaid prior to July 15, 2022.
The Indenture contains provisions for defeasance at any time of the entire indebtedness of this Security or certain restrictive covenants and
Events of Default with respect to this Security, in each case upon compliance with certain conditions set forth in the Indenture.
If an
Event of Default with respect to Securities of this series shall occur and be continuing, the principal of the Securities of this series may be declared due and payable in the manner and with the effect provided in the Indenture.
The Indenture permits, with certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations
of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the Company and the Trustee with the consent of the Holders of not less than a majority in principal amount of the
Securities at the time Outstanding of each series to be affected. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Securities of each series at the time Outstanding, on behalf of the
Holders of all Securities of such series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Security
shall be conclusive and binding upon such Holder and upon all future Holders of this Security and of any Security issued upon the registration of transfer hereof or in exchange herefor or in lieu hereof, whether or not notation of such consent or
waiver is made upon this Security.
As provided in and subject to the provisions of the Indenture, the Holder of this Security shall not
have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing
Event of Default with respect to the Securities of this series, the Holders of not less than 25% in principal amount of the Securities of this series at the time Outstanding shall have made written request to the Trustee to institute proceedings in
respect of such Event of Default as Trustee and offered the Trustee indemnity, security, or both reasonably satisfactory to the Trustee against the costs, expenses and liabilities to be incurred in compliance with such request, and the Trustee shall
not have received from the Holders of a majority in principal amount of Securities of this series at the time Outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for sixty (60) days
after receipt of such notice, request and offer of indemnity and/or security. The foregoing shall not apply to any suit instituted by the Holder of this Security for the enforcement of any payment of principal hereof or any premium or interest
hereon on or after the respective due dates expressed herein.
2
No reference herein to the Indenture and no provision of this Security or of the Indenture shall
alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any premium and interest on this Security at the times, place and rate, and in the coin or currency, herein prescribed.
As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Security is registrable in the
Security Register, upon surrender of this Security for registration of transfer at the office or agency of the Company in any place where the principal of and any premium and interest on this Security are payable, duly endorsed by, or accompanied by
a written instrument of transfer in form satisfactory to the Company and the Security Registrar duly executed by, the Holder hereof or his attorney duly authorized in writing, and thereupon one or more new Securities of this series and of like
tenor, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees.
The Securities of this series are issuable only in registered form without coupons in denominations of $25 and any integral multiples of $25
in excess thereof. As provided in the Indenture and subject to certain limitations therein set forth, Securities of this series are exchangeable for a like aggregate principal amount of Securities of this series and of like tenor of a different
authorized denomination, as requested by the Holder surrendering the same.
No service charge shall be made for any such registration of
transfer or exchange, but the Company, the Trustee, or the Security Registrar may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith.
Prior to due presentment of this Security for registration of transfer, the Company, the Trustee, or the Security Registrar and any agent of
the Company, the Trustee, or the Security Registrar shall treat the Person in whose name this Security is registered as the owner hereof for all purposes, whether or not this Security be overdue, and none of the Company, the Trustee, the Security
Registrar, or any agent thereof shall be affected by notice to the contrary.
All terms used in this Security which are defined in the
Indenture shall have the meanings assigned to them in the Indenture.
The Indenture and this Security shall be governed by and construed
in accordance with the laws of the State of New York, without regard to principles of conflicts of laws.
3
Exhibit h(3)
TRIPLEPOINT VENTURE GROWTH BDC CORP.
$65,000,000
5.75% NOTES DUE 2022
Dated: July 11, 2017
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
Page
|
|
|
SECTION 1.
|
|
Representations and Warranties
|
|
|
3
|
|
|
|
|
|
|
SECTION 2.
|
|
Sale and Delivery to Underwriters; Closing.
|
|
|
19
|
|
|
|
|
|
|
SECTION 3.
|
|
Covenants
|
|
|
21
|
|
|
|
|
|
|
SECTION 4.
|
|
Payment of Expenses
|
|
|
26
|
|
|
|
|
|
|
SECTION 5.
|
|
Conditions of Underwriters’ Obligations
|
|
|
26
|
|
|
|
|
|
|
SECTION 6.
|
|
Indemnification
|
|
|
30
|
|
|
|
|
|
|
SECTION 7.
|
|
Contribution.
|
|
|
32
|
|
|
|
|
|
|
SECTION 8.
|
|
Representations, Warranties and Agreements to Survive Delivery.
|
|
|
34
|
|
|
|
|
|
|
SECTION 9.
|
|
Termination of Agreement.
|
|
|
34
|
|
|
|
|
|
|
SECTION 10.
|
|
Default by One or More of the Underwriters.
|
|
|
35
|
|
|
|
|
|
|
SECTION 11.
|
|
Notices
|
|
|
36
|
|
|
|
|
|
|
SECTION 12.
|
|
Parties
|
|
|
36
|
|
|
|
|
|
|
SECTION 13.
|
|
GOVERNING LAW AND TIME
|
|
|
36
|
|
|
|
|
|
|
SECTION 14.
|
|
Effect of Headings
|
|
|
36
|
|
|
|
|
|
|
SECTION 15.
|
|
Definitions
|
|
|
37
|
|
|
|
|
|
|
SECTION 16.
|
|
Absence of Fiduciary Relationship
|
|
|
40
|
|
|
|
|
|
|
SECTION 17.
|
|
Research Analyst Independence
|
|
|
41
|
|
|
|
|
|
|
SECTION 18.
|
|
Trial By Jury
|
|
|
41
|
|
|
|
|
|
|
SECTION 19.
|
|
Consent to Jurisdiction
|
|
|
41
|
|
- i -
EXHIBITS
|
|
|
|
|
|
|
Exhibit A
|
|
—
|
|
Underwriters and Allocations
|
|
Exhibit B
|
|
—
|
|
Pricing Term Sheet
|
|
Exhibit C
|
|
—
|
|
Form of Opinion of Counsel
|
|
Exhibit D
|
|
—
|
|
Subsidiaries of the Company
|
- ii -
TRIPLEPOINT VENTURE GROWTH BDC CORP.
5.75% Notes Due 2022
UNDERWRITING AGREEMENT
July 11, 2017
Keefe, Bruyette &
Woods, Inc.
Morgan Stanley & Co. LLC
Deutsche Bank
Securities Inc.
As representatives of the several Underwriters named in Exhibit A hereto
c/o Keefe, Bruyette & Woods, Inc.
787 Seventh Avenue
New York, New York 10019
c/o Morgan Stanley & Co.
LLC
1585 Broadway
New York, New York 10036
c/o Deutsche Bank Securities Inc.
60 Wall Street
New York, NY 10005
Ladies and Gentlemen:
TriplePoint Venture Growth BDC Corp., a Maryland corporation (the “
Company
”), TPVG Advisers LLC, a Delaware limited
liability company and a registered investment adviser under the Advisers Act (the “
Adviser
”), and TPVG Administrator LLC, a Delaware limited liability company (the “
Administrator
”), each confirms with Keefe,
Bruyette & Woods, Inc., Morgan Stanley & Co. LLC, Deutsche Bank Securities Inc. and each of the other underwriters named in Exhibit A hereto (collectively, the “
Underwriters
,” which term shall also include any
underwriter substituted as hereinafter provided in Section 10 hereof), for whom Keefe, Bruyette & Woods, Inc., Morgan Stanley & Co. LLC and Deutsche Bank Securities Inc. are acting as representatives (in such capacity, the
“
Representatives
”), with respect to the issue and sale by the Company of a total of $65,000,000 aggregate principal amount of 5.75% Notes due 2022 of the Company (the “
Initial Securities
”), and the purchase by the
Underwriters, acting severally and not jointly, of the respective aggregate principal amounts of Initial Securities set forth in Exhibit A hereto, and with respect to the grant by the Company to the Underwriters, acting severally and not jointly, of
the option described in Section 2(b) hereof to purchase additional Securities (as hereinafter defined) to cover overallotments, if any (the “
Option Securities
”). The Initial Securities and the Option Securities are
hereinafter called, collectively, the “
Securities
.” Certain terms used in this Agreement are defined in Section 15 hereof.
- 1 -
The Company understands that the Underwriters propose to make a public offering of the Securities
as soon as the Representatives deem advisable after this Agreement has been executed and delivered.
The Securities will be issued
under an indenture dated as of July 31, 2015 (the “
Base Indenture
”), as supplemented by the Second Supplemental Indenture to be dated as of July 14, 2017 (the “
Second Supplemental Indenture
” and, together
with the Base Indenture, the “
Indenture
”) between the Company and U.S. Bank National Association, as trustee (the “
Trustee
”). The Securities will be issued to Cede & Co., as nominee of the Depository Trust
Company (“
DTC
”) pursuant to a blanket letter of representations dated as of March 3, 2014, between the Company and DTC.
Promptly after the execution and delivery of this Agreement, the Company will prepare and file with the Commission a prospectus dated
July 11, 2017 in accordance with the provisions of Rule 430C and Rule 497 of the 1933 Act, and the Company has previously advised you of all information (financial and other) that will be set forth therein. Such prospectus, in the
form first furnished to the Underwriters for use in connection with the offering of the Securities (whether to meet the request of purchasers pursuant to Rule 173(d) or otherwise), is herein called the “
Prospectus
.”
Prior to the Execution Date and the purchase of the Initial Securities by the Underwriters on the Closing Date referred to in
Section 2(c), the following transactions occurred:
(a) On June 28, 2013, the Company was formed as a Maryland corporation.
(b) On February 18, 2014, the Company entered into an Investment Advisory Agreement with the Adviser (the “
Investment
Advisory Agreement
”).
(c) On February 18, 2014, the Company entered into an Administration Agreement with the
Administrator (the “
Administration Agreement
”).
(d) On February 18, 2014, the Company entered into a License
Agreement with TriplePoint Capital LLC (the “
License Agreement
”).
(e) On February 18, 2014, the Adviser entered
into a Staffing Agreement with TriplePoint Capital LLC (the “
Staffing Agreement
”).
(f) On February 21, 2014, the
Company entered into a receivables financing agreement, which was amended by Letter Agreements on June 5, 2014, July 18, 2014, August 8, 2014, November 18, 2014 and January 27, 2016 (collectively, the
“
Letter Agreements
”), by and among TPVG Variable Funding Company LLC, as borrower, the Company, as collateral manager and as sole equityholder, Portfolio Financial Servicing Company, as backup collateral manager, U.S. Bank National
Association, as custodian, the agents from time to time party thereto, the lenders from time to time parties thereto, and Deutsche Bank AG, New York Branch, as administrative agent (collectively with the related pledge agreement, blocked account
control agreement and the Letter Agreements, the “
Credit Facility Agreement
”).
- 2 -
(g) On March 5, 2014, the Company filed the 1940 Act Notification with the Commission under
the 1940 Act and the 1940 Act Regulations, pursuant to which the Company elected to be regulated as a business development company (a “
BDC
”).
The Investment Advisory Agreement, Administration Agreement, License Agreement, Staffing Agreement and the Credit Facility Agreement are
hereinafter called, collectively, the “
Fund Agreements
.”
SECTION 1.
Representations and Warranties.
(a)
Representations and Warranties by the Company, the Adviser and the Administrator
.
The Company, the Adviser and
the Administrator, jointly and severally, represent and warrant to each Underwriter as of the date hereof, as of the Applicable Time, as of the Closing Date referred to in Section 2(c) hereof, and as of each Option Closing Date (if any)
referred to in Section 2(b) hereof, and agree with each Underwriter, as follows:
(i)
Compliance with Registration
Requirements
.
The Company has prepared and filed with the Commission the Registration Statement (File No. 333-204933) on Form N-2, including a related Preliminary Prospectus for registration under the 1933 Act of the offering
and sale of the Securities. The Company has filed one or more pre-effective amendments thereto, each including a related Preliminary Prospectus, and each of which has previously been furnished to the Representatives. The Indenture has been duly
qualified under the Trust Indenture Act of 1939, as amended (the
“
1939 Act
”). The Company will next file with the Commission the Prospectus in accordance with Rules 430C and 497 of the 1933 Act. The Company has included
in such Registration Statement, as amended at the Effective Date, all information (other than Rule 430C Information) required to be included by the 1933 Act. As filed, the Prospectus shall contain all Rule 430C Information, together with
all other required information, and shall be in all substantive respects in the form furnished to you prior to the Execution Time or, to the extent not completed at the Execution Time, shall contain only such specific additional information and
other changes (beyond that contained in the latest Preliminary Prospectus) as the Company has advised you, prior to the Execution Time, will be included or made therein.
The offer and sale of the Securities has been registered under the 1933 Act pursuant to the Registration Statement. The Registration
Statement and any post-effective amendments thereto have been declared effective under the 1933 Act and any Rule 462(b) Registration Statement has become effective under the 1933 Act or, not later than 5:00 P.M. (New York City time)
on the business day immediately after the Execution Date, will become effective under the 1933 Act, and no stop order suspending the effectiveness of the Registration Statement or any Rule 462(b) Registration Statement or preventing or
suspending the use of any Preliminary Prospectus or the Prospectus has been issued under the 1933 Act and no proceedings for that purpose have been instituted or are pending or, to the knowledge of the Company, are contemplated by the Commission,
and any request on the part of the Commission for additional information has been complied with. From the time of initial filing of the Registration Statement to the Commission through the date hereof, the Company has been and is an “emerging
growth company,” as defined in Section 2(a)(xix) of the 1933 Act (an “
EGC
”).
- 3 -
At the respective times that the 1940 Act Notification was filed with the Commission, and the
times that the Registration Statement, any Rule 462(b) Registration Statement and any amendments to any of the foregoing were declared or became effective, as the case may be, and at the Closing Date (and, if any Option Securities are
purchased, at the applicable Option Closing Date), the 1940 Act Notification, the Registration Statement, any Rule 462(b) Registration Statement and any amendments to any of the foregoing complied and will comply in all material respects
with the applicable requirements of the 1933 Act, the 1933 Act Regulations, the 1940 Act and the 1940 Act Regulations and did not and will not contain an untrue statement of a material fact or omit to state a material fact required to be stated
therein or necessary in order to make the statements therein not misleading.
At the respective times the Prospectus or any amendment or
supplement thereto was filed pursuant to Rule 497 or issued, at the Closing Date (and, if any Option Securities are purchased, at the applicable Option Closing Date), and at any time when a prospectus is required (or, but for the provisions of
Rule 172, would be required) by applicable law to be delivered in connection with sales of Securities (whether to meet the requests of purchasers pursuant to Rule 173(d) or otherwise), neither the Prospectus nor any amendments or
supplements thereto included or will include an untrue statement of a material fact or omitted or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading.
As of the Applicable Time (except in the case of clause (z) below) and as of each time prior to the Closing Date that
an investor agrees (orally or in writing) to purchase or, if applicable, reconfirms (orally or in writing) an agreement to purchase any Securities from the Underwriters, neither (x) the Pre-Pricing Prospectus as of the Applicable Time and the
information, if any, included on Exhibit B hereto, all considered together (collectively, the “
General Disclosure Package
”), nor (y) any Sales Material considered together with the Pre-Pricing Prospectus as of the
Applicable Time, nor (z) any Rule 482 Material, when considered together with the General Disclosure Package, included or will include an untrue statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not misleading. Any Rule 482 Material, when used, complied with the requirements pertaining thereto as set forth in Rule 482 under the 1933 Act.
Each Preliminary Prospectus and the Prospectus and any amendments or supplements to any of the foregoing filed as part of the Registration
Statement or any amendment thereto, or filed pursuant to Rule 497 under the 1933 Act, or delivered to the Underwriters for use in connection with the offering of the Securities, complied when so filed or when so delivered, as the case may be,
in all material respects with the 1933 Act, the 1933 Act Regulations, the 1940 Act and the 1940 Act Regulations.
The representations and
warranties in the preceding paragraphs of this Section 1(a)(i) do not apply to statements in or omissions from the Registration Statement, any Preliminary Prospectus, the Prospectus or any Rule 482 Material or any amendment or
supplement to any the foregoing made in reliance upon and in conformity with written information furnished to the Company by or on behalf of any Underwriter through the Representatives expressly for use in the Registration Statement, including the
part of the
- 4 -
Registration Statement that constitutes the Statement of Eligibility and Qualification under the 1939 Act (Form T-1) of the Trustee under the Indenture, it being understood and agreed that the
only such information furnished by or on behalf of the Underwriters as aforesaid consists of the information described as such in Section 6(c) hereof.
The copies of the Registration Statement and any Rule 462(b) Registration Statement and any amendments to any of the foregoing and
the copies of each Preliminary Prospectus and Rule 482 Material that is required to be filed with the Commission pursuant to Rule 482 and the Prospectus and any amendments or supplements to any of the foregoing, that have been or
subsequently are delivered to the Underwriters in connection with the offering of the Securities (whether to meet the request of purchasers pursuant to Rule 173(d) or otherwise) were and will be identical to the electronically transmitted
copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T. For purposes of this Agreement, references to the “delivery” or “furnishing” of any of the foregoing documents to the
Underwriters, and any similar terms, include, without limitation, electronic delivery.
Any Rule 482 Material (if any), as of its
issue date and at all subsequent times through the completion of the public offering and sale of the Securities, did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the
Registration Statement, any Preliminary Prospectus or the Prospectus that has not been superseded or modified.
(ii)
Investment Company
Act
.
The Company is a closed-end, non-diversified management investment company and has elected to be regulated as a BDC under the 1940 Act, has duly filed the 1940 Act Notification with the Commission and is eligible to make such an
election.
(iii)
Independent Accountants
. The accountants who certified the financial statements and any supporting
schedules included in the Registration Statement, the General Disclosure Package and the Prospectus are independent public accountants as required by the 1933 Act, the 1933 Act Regulations and the PCAOB.
(iv)
Financial Statements
. The financial statements of the Company included in the Registration Statement, the General Disclosure
Package and the Prospectus, together with the related schedules and notes, present fairly the financial position of the Company at the dates indicated and the results of operations, changes in net assets and cash flows of the Company and for the
periods specified; and any such financial statements comply as to form with the applicable accounting requirements of the 1933 Act and the 1940 Act and have been prepared in conformity with GAAP applied on a consistent basis throughout the periods
involved (except as otherwise noted therein); and the other financial and statistical information and data included in the Registration Statement and the Prospectus are accurately derived from such financial statements and the books and records of
the Company, as applicable. All “non-GAAP financial measures” (as such term is defined in the rules and regulations of the Commission), if any, contained in the Registration Statement, the General Disclosure Package and the Prospectus
comply with Item 10 of Regulation S-K of the Commission, to the extent applicable.
- 5 -
(v)
No Material Adverse Change in Business
. Since the respective dates as of which
information is given in the Registration Statement, the General Disclosure Package and the Prospectus (in each case exclusive of any amendments or supplements thereto subsequent to the date of this Agreement), except as otherwise stated therein,
(A) there has been no material adverse change or any development that could be expected to result in a material adverse change in the condition (financial or other), results of operations, business, properties, management or business prospects
of the Company and its subsidiaries taken as a whole, whether or not arising in the ordinary course of business (in any such case, a “
Company Material Adverse Effect
”); and (B) except as otherwise disclosed in the General
Disclosure Package and the Prospectus (in each case exclusive of any amendments or supplements thereto subsequent to the date of this Agreement), the Company has not incurred any liability or obligation or entered into any transaction or agreement
that, individually or in the aggregate, is material with respect to the Company and its subsidiaries, taken as a whole, and the Company has not sustained any loss or interference with its business or operations from fire, explosion, flood,
earthquake or other natural disaster or calamity, whether or not covered by insurance, or from any labor dispute or disturbance or court or governmental action, order or decree which could be expected, individually or in the aggregate, to result in
a Company Material Adverse Effect.
(vi)
Good Standing of the Company
. The Company has been duly incorporated and is validly
existing as a corporation in good standing under the laws of the State of Maryland and has power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the General Disclosure
Package and the Prospectus and to enter into and perform its obligations under this Agreement and the Fund Agreements (other than the Staffing Agreement); and the Company is duly qualified as a foreign corporation to transact business and is in good
standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except (solely in the case of jurisdictions other than the State of Maryland) where the
failure so to qualify or to be in good standing would not, individually or in the aggregate, result in a Company Material Adverse Effect.
(vii)
Subsidiaries
. Except for the entities listed on Exhibit D hereto, the Company has no subsidiaries.
(viii)
Capitalization
. The authorized, issued and outstanding capital stock of the Company as of March 31, 2017 is as set forth in
the column entitled “Actual” and in the corresponding line items under the caption “Capitalization” in the Pre-Pricing Prospectus and the Prospectus. After giving effect to the purchase of the Initial Securities by the
Underwriters on the Closing Date, the authorized, issued and outstanding capital stock of the Company will be as set forth in the column entitled “As Adjusted” and in the corresponding line items under the caption
“Capitalization” (in each case except for any Option Securities issued by the Company pursuant to this Agreement and issuances, if any, subsequent to the date of this Agreement pursuant to employee or director stock option, stock purchase
or other equity incentive plans or any dividend reinvestment plan described in the Pre-Pricing Prospectus and the Prospectus upon the exercise of options issued pursuant to any such stock option, stock purchase or other equity incentive plans as so
described, or upon the exercise of options or the conversion of convertible securities described in the General Disclosure Package and the Prospectus). The shares of issued and outstanding capital stock of the Company have been duly authorized and
validly issued and are fully paid and non-assessable; and none of the outstanding shares of capital stock of the Company was issued in violation of any preemptive rights, rights of first refusal or other similar rights of any securityholder of the
Company or any other person.
- 6 -
(ix)
Authorization, Validity and Enforceability of Agreements
. This Agreement, the Fund
Agreements (other than the Staffing Agreement) and the Indenture have been duly authorized, executed and delivered by the Company. Each of the Fund Agreements (other than the Staffing Agreement) and the Indenture constitute valid, binding and
enforceable agreements of the Company, subject, as to enforcement, to applicable bankruptcy, reorganization, insolvency, moratorium or other laws affecting creditors’ rights generally. The Investment Advisory Agreement has been approved by the
Company’s board of directors in accordance with Section 15 of the 1940 Act and contains the applicable provisions required by Section 15 of the 1940 Act and Section 205 of the Advisers Act.
(x)
Authorization of Securities
.
The Company has all requisite corporate power and authority to execute, deliver and perform
each of its obligations under the Securities; the Securities, when issued, will be in the form contemplated by the Indenture; the Securities have been duly authorized by the Company and, when executed by the Company and authenticated by the Trustee
in accordance with the provisions of the Indenture and when delivered to and paid for by the Underwriters in accordance with the terms of this Agreement, will constitute valid and binding obligations of the Company, entitled to the benefits of the
Indenture, and enforceable against the Company in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to or affecting the rights and
remedies of creditors or by general equitable principles and except as rights to indemnity and contribution hereunder and thereunder may be limited by general equitable principles or federal or state securities laws or public policy underlying such
laws.
(xi)
Description of Securities
. The Securities, the Company’s Organizational Documents, and the Indenture
conform in all material respects to all of the respective statements relating thereto contained in the Registration Statement, the General Disclosure Package and the Prospectus, and such statements conform to the rights set forth in the respective
instruments and agreements defining the same.
(xii)
Absence of Defaults and Conflicts
. The Company is not in violation of its
Organizational Documents or in default in the performance or observance of any obligation, agreement, covenant or condition contained in any Company Document, except (solely in the case of Company Documents) for such defaults that would not,
individually or in the aggregate, result in a Company Material Adverse Effect. The execution, delivery and performance of this Agreement, the Fund Agreements (other than the Staffing Agreement), the Securities, the Indenture and the consummation of
the transactions contemplated herein and in the Registration Statement, the General Disclosure Package and the Prospectus (including the issuance and sale of the Securities and the use of the proceeds from the sale of the Securities as described in
the Pre-Pricing Prospectus and the Prospectus under the caption “Use of Proceeds”) and compliance by the Company with its obligations under this Agreement, the Fund Agreements (other than the Staffing Agreement), the Indenture and the
Securities do not and will not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or
- 7 -
default, or Repayment Event under, or result in the creation or imposition of any Lien upon any property or assets of the Company pursuant to, any Company Documents, except (solely in the case of
Company Documents) for such conflicts, breaches, defaults or Liens that would not, individually or in the aggregate, result in a Company Material Adverse Effect, nor will such action result in any violation of (i) the provisions of the
Organizational Documents of the Company or (ii) any applicable law, statute, rule, regulation, judgment, order, writ or decree of any government, government instrumentality or court, domestic or foreign, having jurisdiction over the Company or
any of its assets, properties or operations.
(xiii)
No Employees
. As of the date hereof, the Company does not have, and on the
Closing Date the Company will not have, any employees.
(xiv)
Absence of Proceedings
. There is no action, suit, proceeding, inquiry
or investigation before or brought by any court or governmental agency or body, domestic or foreign, now pending, or, to the knowledge of the Company, threatened, against or affecting the Company which is required to be disclosed in the Registration
Statement, the Pre-Pricing Prospectus or the Prospectus (other than as disclosed therein), or which might reasonably be expected, individually or in the aggregate, to result in a Company Material Adverse Effect, or which might be expected to
materially and adversely affect the consummation of the transactions contemplated in this Agreement, the Fund Agreements, the Securities or the Indenture or the performance by the Company of its obligations under this Agreement and the Fund
Agreements (other than the Staffing Agreement); the aggregate of all pending legal or governmental proceedings to which the Company is a party or of which any of their respective property or assets is the subject which are not described in the
Registration Statement, the Pre-Pricing Prospectus and the Prospectus, including ordinary routine litigation incidental to the business, could not reasonably be expected, individually or in the aggregate, to result in a Company Material Adverse
Effect.
(xv)
Accuracy of Descriptions and Exhibits
. The information in the Pre-Pricing Prospectus and the Prospectus under the
captions “Risk Factors,” “Description of Capital Stock,” “Regulation,” “Related Party Transactions and Certain Relationships,” “Certain U.S. Federal Income Tax Considerations” and “Material U.S.
Federal Income Tax Considerations,” in each case to the extent that it constitutes matters of law, summaries of legal matters, summaries of provisions of the Company’s Organizational Documents or any other instruments or agreements,
summaries of legal proceedings, or legal conclusions, fairly summarizes the matters described therein in all material respects; all descriptions in the Registration Statement, the General Disclosure Package and the Prospectus of any other Company
Documents are accurate in all material respects; and there are no franchises, contracts, indentures, mortgages, deeds of trust, loan or credit agreements, bonds, notes, debentures, evidences of indebtedness, leases or other instruments, agreements
or documents required to be described or referred to in the Registration Statement, the Pre-Pricing Prospectus or the Prospectus or to be filed as exhibits to the Registration Statement which have not been so described and filed as required.
(xvi)
Possession of Intellectual Property
. The Company owns or has obtained valid and enforceable licenses or other rights to use, all
patents, patent rights, patent applications, licenses, copyrights, inventions, know-how (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service
- 8 -
marks, trade names, service names, software, internet addresses, domain names and other intellectual property
(collectively, “
Intellectual Property
”) that is described in the Registration Statement, the General Disclosure Package or the Prospectus or that is necessary for the conduct of its business as currently conducted, as proposed to be
conducted and as described in the Registration Statement, the General Disclosure Package and the Prospectus, except where the failure to own, license or have such rights would not have a Company Material Adverse Effect; the Company has not received
any notice and is not otherwise aware of any infringement of, or conflict, with asserted rights of others with respect to any Intellectual Property or of any facts or circumstances which would render any Intellectual Property invalid or inadequate
to protect the interests of the Company which would result in a Company Material Adverse Effect.
(xvii)
Absence of Further
Requirements
. (A) No filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any court or governmental authority or agency, domestic or foreign, (B) no authorization, approval, vote
or consent of any holder of capital stock or other securities of the Company or creditor of the Company, (C) no authorization, approval, waiver or consent under any Subject Instrument, and (D) no authorization, approval, vote or consent of
any other person or entity, is necessary or required for the authorization, execution, delivery or performance by the Company of this Agreement, the Fund Agreements (other than the Staffing Agreement), the Securities or the Indenture for the
offering of the Securities as contemplated by this Agreement, for the issuance, sale or delivery of the Securities to be sold by the Company pursuant to this Agreement, or for the consummation of any of the other transactions contemplated by this
Agreement, the Fund Agreements, the Securities and the Indenture in each case on the terms contemplated by the Registration Statement, the General Disclosure Package and the Prospectus, except such as have been obtained, and except that no
representation is made as to such as may be required under state or foreign securities laws.
(xviii)
Possession of Licenses and
Permits
. The Company possesses such permits, licenses, approvals, consents and other authorizations (collectively, “
Governmental Licenses
”) issued by the appropriate federal, state, local or foreign regulatory agencies or bodies
necessary to conduct the business now operated by them; and, except as would not, individually or in the aggregate, result in a Company Material Adverse Effect, the Company is in compliance with the terms and conditions of all such Governmental
Licenses, all such Governmental Licenses are valid and in full force and effect and the Company has not received any notice of proceedings relating to the revocation or modification of any such Governmental Licenses.
(xix)
Title to Property
. The Company owns or leases or has access to all properties and assets as are necessary to the conduct of its
operations as presently conducted.
(xx)
Environmental Laws
. The Company is not in violation of any statute or any rule,
regulation, decision or order of any governmental agency or body or any court, domestic or foreign, relating to the use, production, disposal or release of hazardous or toxic substances or relating to the protection or restoration of the environment
or human exposure to hazardous or toxic substances (collectively, “
environmental laws
”), owns or operates any real property contaminated with any substance that is subject to any environmental laws, is liable for any off-site
disposal or contamination pursuant to any environmental laws, or is subject to any claim relating to any environmental laws, which violation, contamination, liability or claim,
- 9 -
individually or in the aggregate, would have a material adverse effect on the general affairs, business, prospects, management, financial position, shareholders’ equity or results of
operations of the Company, whether or not arising from transactions in the ordinary course of business; and the Company is not aware of any pending investigation which might lead to such a claim.
(xxi)
Absence of Registration Rights
. There are no persons with registration rights or other similar rights to have any securities
(debt or equity) registered pursuant to the Registration Statement or included in the offering contemplated by this Agreement, and there are no persons with co-sale rights, tag-along rights or other similar rights to have any securities (debt or
equity) included in the offering contemplated by this Agreement or sold in connection with the sale of Securities pursuant to this Agreement.
(xxii)
FINRA Matters
. All of the information provided to the Representatives or to counsel for the Underwriters by the Company in
connection with any letters, filings or other supplemental information provided to FINRA pursuant to FINRA Rule 2310, 5110 or 5121 is true, complete and correct in all material respects.
(xxiii)
Tax Returns
.
The Company has filed all foreign, federal, state and local tax returns that are required to be filed or
have requested extensions thereof, except where the failure to file would not, individually or in the aggregate, result in a Company Material Adverse Effect, and have paid all taxes (including, without limitation, any estimated taxes) required to be
paid and any other assessment, fine or penalty levied it, to the extent that any of the foregoing is due and payable, except for any such tax, assessment, fine or penalty that is currently being contested in good faith by appropriate actions and
except for such taxes, assessments, fines or penalties the nonpayment of which would not, individually or in the aggregate, result in a Company Material Adverse Effect.
(xxiv)
Insurance
. The Company is insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which it is engaged; all policies of insurance and any fidelity or surety bonds insuring the Company, its business, assets, officers and directors are in full force and effect; the Company is
in compliance with the terms of such policies and instruments in all material respects; there are no claims by the Company under any such policy or instrument as to which any insurance company is denying liability or defending under a reservation of
rights clause; the Company has not been refused any insurance coverage sought or applied for; and the Company has no reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain
similar coverage from similar insurers at a cost that would not, individually or in the aggregate, result in a Company Material Adverse Effect.
(xxv)
Accounting and Disclosure Controls
. The Company maintains disclosure controls and procedures (as such term is defined in
Rule 13a-15(e)
of the 1934 Act) that comply with the requirements of the 1934 Act and such disclosure controls and procedures are effective. The Company has established and maintains effective “internal
control over financial reporting” (as defined in Rule 13a-15 of the 1934 Act Regulations). The Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that (A) transactions are executed in
accordance with management’s general or specific authorizations and with the investment objectives, policies and restrictions of the Company and the applicable
- 10 -
requirements of the 1940 Act and the 1940 Act Regulations; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset accountability and to maintain material compliance with the books and records requirements under the 1940 Act and the 1940 Act Regulations; (C) access to assets is permitted only in accordance with management’s general or specific
authorization; and (D) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described in the Registration Statement, the
General Disclosure Package and the Prospectus, since the end of the Company’s most recent audited fiscal year, there has been (1) no material weakness (as defined in Rule 1-02 of Regulation S-X of the Commission) in the Company’s
internal control over financial reporting (whether or not remediated), and (4) no change in the Company’s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the
Company’s internal control over financial reporting.
(xxvi)
Compliance with the Sarbanes-Oxley Act
. There is and has been no
failure on the part of the Company or any of the Company’s directors or officers, in their capacities as such, to comply with any provision of the Sarbanes-Oxley Act with which any of them is required to comply, including Section 402
related to loans.
(xxvii)
Absence of Manipulation
. The Company has not taken and will not take, directly or indirectly, any action
designed to or that would constitute or that might reasonably be expected to cause or result in the stabilization or manipulation of the price of any security to facilitate the sale or resale of the Securities.
(xxviii)
Statistical and Market-Related Data
. Any statistical and market-related data included in the Registration Statement, the
General Disclosure Package or the Prospectus are based on or derived from sources that the Company believes to be reliable and accurate and accurately reflect the materials upon which such data is based or from which it was derived, and the Company
has delivered true, complete and correct copies of such materials to the Representatives.
(xxix)
Foreign Corrupt Practices Act
.
Neither the Company, the Adviser, nor the Administrator nor, to the knowledge of the Company, the Adviser, the Administrator, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company, is aware of or has taken
any action, directly or indirectly, that has resulted or would result in a violation by any such person of the FCPA, including, without limitation, any offer, payment, promise to pay or authorization of the payment of any money or other property,
gift, promise to give, or authorization of the giving of anything of value to any “foreign official” (as such term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in
contravention of the FCPA, and the Company, the Adviser and the Administrator, and, to the knowledge of the Company, the Adviser and the Administrator, their other affiliates have conducted their businesses in compliance with the FCPA and have
instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to ensure, continued compliance therewith.
- 11 -
(xxx)
Money Laundering Laws
. The operations of the Company, the Adviser and the
Administrator are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III of the Uniting and Strengthening America by
Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable anti-money laundering statutes of jurisdictions where the Company conducts business, the rules and regulations thereunder
and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “
Anti-Money Laundering Laws
”), and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Company, the Adviser or the Administrator with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, the Adviser or the Administrator, is
threatened.
(xxxi)
OFAC
. Neither the Company, the Adviser, nor the Administrator nor, to the knowledge of the Company, the
Adviser, the Administrator, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company, is currently subject to any sanctions administered or enforced by OFAC (the “
Sanctions
”) or is located,
organized or resident in a country or territory that is the subject of Sanctions; and the Company will not, directly or indirectly, use any of the proceeds received by the Company from the sale of Securities by the Company in the offering
contemplated by this Agreement, or lend, contribute or otherwise make available any such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of funding or facilitating any activities or business of or with
any person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions, or in any other manner that will result in a violation of Sanctions. The Company, the Adviser and the Administrator have not
knowingly engaged in, are not now knowingly engaged in, and will not engage in, any dealings or transactions with any individual or entity, or in any country or territory, that at the time of the dealing or transaction is or was the subject of
Sanctions.
(xxxii)
Lending and Other Relationship
. Except as disclosed in the Registration Statement, the General Disclosure
Package and the Prospectus, (i) neither the Company, the Adviser nor the Administrator has any lending or similar relationship with any Underwriter or any bank or other lending institution affiliated with any Underwriter; (ii) the Company
will not, directly or indirectly, use any of the proceeds received by the Company from the sale of the Securities by the Company hereunder to reduce or retire the balance of any loan or credit facility extended by any Underwriter or any of its
“affiliates” or “associated persons” (as such terms are used in FINRA Rule 5121) or otherwise direct any such proceeds to any Underwriter or any of its “affiliates” or “associated persons” (as so
defined); and (iii) there are and have been no transactions, arrangements or dealings between the Company, on one hand, and any Underwriter or any of its “affiliates” or “associated persons” (as so defined), on the other
hand, that, under FINRA Rule 5110 or 5121, must be disclosed in a submission to FINRA in connection with the offering of the Securities contemplated hereby or disclosed in the Registration Statement, the General Disclosure Package or
Prospectus.
(xxxiii)
Changes in Management
. Except as disclosed in the Registration Statement, the General Disclosure Package and
the Prospectus, none of the persons who were officers or directors of the Company as of the date of the Pre-Pricing Prospectus has given oral or written notice to the Company of his or her resignation (or otherwise indicated to the Company an
intention to resign within the next 24 months), nor has any such officer or director
- 12 -
been terminated by the Company or otherwise removed from his or her office or from the board of directors, as the case may be (including, without limitation, any such termination or removal which
is to be effective as of a future date) nor is any such termination or removal under consideration by the Company or its board of directors.
(xxxiv)
Transfer Taxes
. There are no stock or other transfer taxes, stamp duties, capital duties or other similar duties, taxes or
charges payable in connection with the execution or delivery of this Agreement by the Company or the issuance or sale by the Company of the Securities to be sold by the Company to the Underwriters hereunder.
(xxxv)
Related Party Transactions
. There are no business relationships or related party transactions involving the Company or, to the
knowledge of the Company, any other person that are required to be described in the Pre-Pricing Prospectus or the Prospectus that have not been described as required.
(xxxvi)
Portfolio Companies
. The Company holds valid and binding agreements with respect to each investment under the
Section “Portfolio Companies” in the Pre-Pricing Prospectus and the Prospectus (each a “
Portfolio Company Agreement
”) with corporations or other entities (each a “
Portfolio Company
”). Except as
otherwise disclosed in the General Disclosure Package and the Prospectus, and to the Company’s knowledge, each Portfolio Company is current, in all material respects, with all its obligations under the applicable Portfolio Company Agreements,
no event of default (or a default which with the giving of notice or the passage of time would become an event of default) has occurred under such agreements, except to the extent that any such failure to be current in its obligations and any
such default would not reasonably be expected to result in a Company Material Adverse Effect.
(xxxvii)
Offer and Sale of
Securities
. The Company has taken all required action under the 1933 Act, the 1933 Act Regulations, the 1940 Act, the 1940 Act Regulations and the 1939 Act to make the public offering and consummate the sale of the Securities as contemplated by
this Agreement.
(xxxviii)
Relationships with Directors, Officers and Stockholders
.
Except as described in the Registration
Statement, the General Disclosure Package and the Prospectus, no relationship, direct or indirect, exists between or among the Company, on the one hand, and the directors, officers or stockholders of the Company, on the other hand, that is required
to be described in the Registration Statement, the General Disclosure Package and the Prospectus, which is not so described.
(xxxix)
Interested Persons
. Except as disclosed in the Registration Statement and the Prospectus, no director of the Company is an
“interested person” (as defined in the 1940 Act) of the Company or an “affiliated person” (as defined in the 1940 Act) of any Underwriter listed in Exhibit A hereto.
(xl)
Sales Material
. All Sales Material complied and comply in all material respects with the applicable requirements of the 1933 Act,
1933 Act Regulations, the 1940 Act and 1940 Act Regulations and, if required to be filed with FINRA under FINRA’s conduct rules, were provided to Fried, Frank, Harris, Shriver & Jacobson LLP (“
Fried Frank
”), counsel
for the
- 13 -
Underwriters, for filing. No Sales Material contained or contains an untrue statement of a material fact or omitted or omits to state a material fact necessary in order to make the statements
therein, in the light of the circumstances under which they were made, not misleading.
(xli)
Directors’ and Officers’
Insurance and Fidelity Bond
. On the Closing Date and each Option Closing Date, the Company’s directors’ and officers’ errors and omissions insurance policy and its fidelity bond required by Rule 17g-1 of the 1940 Act
Regulations will be in full force and effect; the Company is in compliance with the terms of such policy and fidelity bond in all material respects; and there are no claims by the Company under any such policy or fidelity bond as to which any
insurance company is denying liability or defending under a reservation of rights clause; the Company has not been refused any insurance coverage sought or applied for; and the Company has no reason to believe that it will not be able to renew its
existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not have a Company Material Adverse Effect, except as set forth in or
contemplated in the Registration Statement and the Prospectus (exclusive of any supplement thereto).
(xlii)
Compliance with RIC
Requirements
. The Company intends to direct the investment of the net proceeds of the offering of the Securities and to continue to conduct its activities in such a manner as to continue to comply with the requirements for qualification and
taxation as a RIC under Subchapter M of the Code. The Company has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code commencing with its taxable year ended December 31, 2014.
(xliii)
1940 Act Notification
. The Company has elected to be regulated as a BDC under the 1940 Act and has filed with the Commission,
pursuant to Section 54(a) of the 1940 Act, a duly completed and executed Form N-54A; the Company has not filed with the Commission any notice of withdrawal of the 1940 Act Notification pursuant to Section 54(c) of the 1940
Act; the 1940 Act Notification remains in full force and effect, and, to the Company’s knowledge, no order of suspension or revocation of such election under the 1940 Act has been issued or proceedings therefore initiated or threatened by the
Commission. The operations of the Company are in compliance in all material respects with the applicable provisions of the 1940 Act and the 1940 Act Regulations.
(xliv)
Offering Materials
. The Company has not distributed, directly or indirectly (other than through the Underwriters), any
“written communication” (as defined in Rule 405 under the 1933 Act) or other offering materials in connection with the offering or sale of the Securities, other than the Pre-Pricing Prospectus, the Prospectus, any Rule 482
Material and any amendment or supplements to any of the foregoing that are filed with the Commission. The Company (a) has not alone engaged in any Testing-the-Waters Communication and (b) has not authorized anyone other than the
Representatives to engage in Testing-the-Waters Communications. The Company reconfirms that the Representatives have been authorized to act on its behalf in undertaking Testing-the-Waters Communications. The Company has not distributed any Written
Testing-the-Waters Communications.
- 14 -
(xlv)
Brokers
. There is no broker, finder or other party that is entitled to receive from
the Company any brokerage or finder’s fee or other fee or commission as a result of any of the transactions contemplated by this Agreement, except for underwriting discounts and commissions payable to the Underwriters in connection with the
sale of the Securities to the Underwriters pursuant to this Agreement.
(b)
Representations and Warranties by the Adviser and
the Administrator
. Each of the Adviser and the Administrator, jointly and severally, represent and warrant to each Underwriter as of the Execution Time, as of the Applicable Time, as of the Closing Date referred to in Section 2(c) hereof,
and as of each Option Closing Date (if any) referred to in Section 2(b) hereof, and agree with each Underwriter, as follows:
(i)
Absence of Manipulation
. Each of the Adviser and the Administrator has not taken, directly or indirectly, any action designed to or
that has constituted or that might reasonably be expected to cause or result, under the 1934 Act or otherwise, in stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.
(ii)
No Material Adverse Change in Business
. Since the respective dates as of which information is given in the Registration Statement,
the General Disclosure Package and the Prospectus (in each case exclusive of any amendments or supplements thereto subsequent to the Execution Time), except as otherwise stated therein, (A) there has been no material adverse change in the
condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Adviser and the Administrator considered as one enterprise, whether or not arising in the ordinary course of business (an
“
Adviser/Administrator Material Adverse Effect
”) and (B) there have been no transactions entered into by the Adviser or the Administrator which are material with respect to the Adviser and the Administrator considered as one
enterprise.
(iii)
Good Standing
. Each of the Adviser and the Administrator has been duly organized and is validly existing as a
limited liability company in good standing under the laws of the State of Delaware and has power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the General Disclosure
Package and the Prospectus and to enter into and perform its obligations under this Agreement and the Fund Agreements, to the extent a party thereto, and each of the Adviser and the Administrator is duly qualified as a limited liability company to
transact business and is in good standing in each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in good
standing would not result in an Adviser/Administrator Material Adverse Effect.
(iv)
Authorization, Validity and Enforceability of
Agreements
. This Agreement and each of the Fund Agreements have been duly authorized, executed and delivered by each of the Adviser and the Administrator, as applicable. Each of the Fund Agreements constitute valid, binding and enforceable
agreements of the Adviser and the Administrator, as applicable, subject, as to enforcement, to applicable bankruptcy, reorganization, insolvency, moratorium or other laws affecting creditors’ rights generally.
- 15 -
(v)
Absence of Defaults and Conflicts
. Neither the Adviser nor the Administrator is in
violation of its Organizational Documents or in default in the performance or observance of any obligation, agreement, covenant or condition contained in any Adviser Document or Administrator Document, except for such defaults that would not result
in an Adviser/Administrator Material Adverse Effect. The execution, delivery and performance of this Agreement and the Fund Agreements, to the extent a party thereto, and the consummation of the transactions contemplated herein and in the
Registration Statement, the General Disclosure Package and the Prospectus (including the issuance and sale of the Securities and the use of the proceeds from the sale of the Securities as described in the General Disclosure Package and the
Prospectus under the caption “Use of Proceeds”) and compliance by each of the Adviser and the Administrator with its obligations under this Agreement and the Fund Agreements, to the extent a party thereto, do not and will not, whether with
or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment Event under, or result in the creation or imposition of any Lien upon any property or assets of the Adviser or the
Administrator pursuant to, any Adviser Document or Administrator Document, except for such conflicts, breaches, defaults or Liens that would not result in an Adviser/Administrator Material Adverse Effect, nor will such action result in any violation
of the provisions of the Organizational Documents of the Adviser or the Administrator, as applicable, or any applicable law, statute, rule, regulation, judgment, order, writ or decree of any government, government instrumentality or court, domestic
or foreign, having jurisdiction over the Adviser or the Administrator or any of their respective assets, properties or operations.
(vi)
Absence of Labor Dispute
. As of the date hereof, neither the Adviser nor the Administrator have, and on the Closing Date, neither the Adviser nor the Administrator will have, any employees. To the knowledge of the Adviser and the
Administrator, no labor dispute with the employees of TriplePoint Capital LLC exists or, to the knowledge of the Adviser and the Administrator, is imminent.
(vii)
Absence of Proceedings
. There is no action, suit, proceeding, inquiry or investigation before or brought by any court or
governmental agency or body, domestic or foreign, now pending, or, to the knowledge of the Adviser or the Administrator, threatened, against or affecting the Adviser or the Administrator which is required to be disclosed in the Registration
Statement, the General Disclosure Package or the Prospectus (other than as disclosed therein), or which might reasonably be expected to result in an Adviser/Administrator Material Adverse Effect, or which might reasonably be expected to materially
and adversely affect the properties or assets thereof or the consummation of the transactions contemplated in this Agreement, the Fund Agreements, the Securities and the Indenture, to the extent a party thereto, or the performance by each of the
Adviser and the Administrator of its obligations under this Agreement and Fund Agreements, to the extent a party thereto. The aggregate of all pending legal or governmental proceedings to which the Adviser or the Administrator is a party or of which
any of their respective property or assets is the subject which are not described in the Registration Statement, the General Disclosure Package and the Prospectus, including ordinary routine litigation incidental to the business, could not
reasonably be expected to result in an Adviser/Administrator Material Adverse Effect.
- 16 -
(viii)
Absence of Misstatements or Omissions
. The description of each of the Adviser and
the Administrator and its business, and the statements attributable to the Adviser and the Administrator, in the Registration Statement and the Prospectus complied and comply in all material respects with the provisions of the 1933 Act, the 1933 Act
Regulations, the 1940 Act, the 1940 Act Regulations, the Advisers Act and the Advisers Act Regulations and did not and will not contain an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made, not misleading.
(ix)
Possession of Intellectual Property
. Each
of the Adviser and Administrator owns, or has obtained valid and enforceable licenses for, or other rights to use, the inventions, patent applications, patents, trademarks (both registered and unregistered), trade names, copyrights, trade secrets
and other proprietary information described in the Registration Statement, the General Disclosure Package and the Prospectus as being licensed by it or which are necessary for the conduct of its businesses, except where the failure to own, license
or have such rights would not, individually or in the aggregate, have an Adviser/Administrator Material Adverse Effect; except as disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, neither the Adviser nor the
Administrator has received notice and is not otherwise aware of any infringement of, or conflict with, asserted rights of third parties with respect to any Intellectual Property or of any facts or circumstances which would render any Intellectual
Property invalid or inadequate to protect the interest of the Adviser or the Administrator, as the case may be, therein, and which infringement or conflict (if the subject of any unfavorable decision, ruling or finding) or invalidity or inadequacy,
would result in an Adviser/Administrator Material Adverse Effect.
(x)
Absence of Further Requirements
. (A) No filing with, or
authorization, approval, consent, license, order, registration, qualification or decree of, any court or governmental authority or agency, domestic or foreign, (B) no authorization, approval, vote or other consent of any holder of securities of
the Adviser, the Administrator or any creditor of the Adviser or the Administrator, (C) no waiver or consent under any Subject Instrument, and (D) no authorization, approval, vote or other consent of any other person or entity, is
necessary or required for the execution, delivery or performance by each of the Adviser and the Administrator of this Agreement, the Fund Agreements and the Indenture, to the extent a party thereto, for the offering, issuance, sale or delivery of
the Securities hereunder, or for the consummation of any of the other transactions contemplated by this Agreement, the Fund Agreements and the Indenture, to the extent a party thereto, in each case on the terms contemplated by the Registration
Statement, the General Disclosure Package and the Prospectus, except such as have been obtained under the 1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act Regulations, the 1940 Act and the 1940 Act Regulations or such as may be
required under state securities laws.
(xi)
Title to Property
. Each of the Adviser and the Administrator owns or leases or has
access to all properties and assets as are necessary to the conduct of its operations as presently conducted.
(xii)
Possession of
Licenses and Permits
. Each of the Adviser and the Administrator possesses such permits, licenses, approvals, consents and other authorizations (collectively, the “
Adviser/Administrator Governmental Licenses
”) issued by the
appropriate federal, state, local or foreign regulatory agencies or bodies necessary to conduct the business
- 17 -
now operated by them; the Adviser and the Administrator are in compliance with the terms and conditions of all such Adviser/Administrator Governmental Licenses, except where the failure so to
comply would not, individually or in the aggregate, have an Adviser/Administrator Material Adverse Effect; all of the Adviser/Administrator Governmental Licenses are valid and in full force and effect, except when the invalidity of such
Adviser/Administrator Governmental Licenses or the failure of such Adviser/Administrator Governmental Licenses to be in full force and effect would not, individually or in the aggregate, have an Adviser/Administrator Material Adverse Effect; and
neither the Adviser nor the Administrator has received any notice of proceedings relating to the revocation or modification of any such Adviser/Administrator Governmental Licenses which, individually or in the aggregate, if the subject of an
unfavorable decision, ruling or finding, would result in an Adviser/Administrator Material Adverse Effect.
(xiii)
Investment Company
Act
. Neither the Adviser nor the Administrator is, and upon the sale of the Securities contemplated under this Agreement and the Fund Agreements, to the extent a party thereto, and the application of the net proceeds therefrom as described in
the General Disclosure Package and the Prospectus under the caption “Use of Proceeds” will not be, an “investment company” or an entity “controlled” by an “investment company” as such terms are defined in the
1940 Act.
(xiv)
Insurance
. Each of the Adviser and the Administrator are insured by insurers of recognized financial
responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which they are engaged; all policies of insurance and any fidelity or surety bonds insuring the Adviser or the Administrator or their
respective businesses, assets, employees, officers and directors are in full force and effect; the Adviser and the Administrator are in compliance with the terms of such policies and instruments in all material respects; there are no claims by the
Adviser or the Administrator under any such policy or instrument as to which any insurance company is denying liability or defending under a reservation of rights clause; neither the Adviser nor the Administrator has been refused any insurance
coverage sought or applied for; and neither the Adviser nor the Administrator has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar
insurers as may be necessary to continue its business at a cost that would not have an Adviser/Administrator Material Adverse Effect.
(xv)
Accounting Controls
. Each of the Adviser and the Administrator maintains a system of internal accounting controls sufficient to
provide reasonable assurance that (A) transactions are executed in accordance with management’s general or specific authorizations, (B) access to assets is permitted only in accordance with management’s general or specific
authorization, and (C) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.
(xvi)
Advisers Act
. The Adviser is registered as an investment adviser under the Advisers Act and is not prohibited by the Advisers
Act, the Advisers Act Regulations, the 1940 Act or the 1940 Act Regulations from acting under the Investment Advisory Agreement for the Company as contemplated by the Prospectus.
- 18 -
(xvii)
Financial Resources
. Each of the Adviser and the Administrator has the financial
resources available to it necessary for the performance of its services and obligations as contemplated in the General Disclosure Package, the Prospectus, this Agreement and the Fund Agreements, to the extent a party thereto, and each of the Adviser
and the Administrator owns, leases or has access to all properties and other assets that are necessary to the conduct of its business and to perform the services, as described in the Registration Statement, the General Disclosure Package and the
Prospectus.
(xviii)
Employment Status
. Neither the Adviser nor the Administrator is aware that (i) any executive, key
employee or significant group of employees of the Company, if any, the Adviser or the Administrator, as applicable, plans to terminate employment with the Company, the Adviser or the Administrator or (ii) any such executive or key employee is
subject to any non-compete, nondisclosure, confidentiality, employment, consulting or similar agreement that would be violated by the present or proposed business activities of the Company, the Adviser or the Administrator except where such
termination or violation would not reasonably be expected to have an Adviser Material Adverse Effect.
(xix)
No
Subsidiaries.
Except for the Administrator, the Adviser has no subsidiaries. The Administrator has no subsidiaries.
(c)
Certificates
.
Any certificate signed by any officer of the Company, the Adviser or the Administrator (whether signed on behalf of such officer or the Company, the Adviser or the Administrator) and delivered to the
Representatives or to counsel for the Underwriters shall be deemed a representation and warranty by the Company, the Adviser or the Administrator, respectively, to each Underwriter as to the matters covered thereby.
SECTION 2.
Sale and Delivery to Underwriters; Closing
.
(a)
Initial Securities
.
On the basis of the representations and warranties herein contained and subject to the
terms and conditions herein set forth, the Company hereby agrees to sell to the Underwriters, severally and not jointly, the respective aggregate principal amount of Initial Securities set forth opposite the name of such Underwriter in
Exhibit A hereto, and each Underwriter, severally and not jointly, agrees to purchase the respective aggregate principal amount of Initial Securities set forth opposite the name of such Underwriter in Exhibit A hereto, plus any additional
aggregate principal amount of Initial Securities which such Underwriter may become obligated to purchase pursuant to the provisions of Section 10 hereof, subject to such adjustments among the Underwriters as the Representatives in their sole
discretion shall make to eliminate any sales or purchases of fractional Securities, in each case at a purchase price of $24.25 per Security (the “
Purchase Price
”).
(b)
Option Securities
.
In addition, on the basis of the representations and warranties herein contained and subject to the terms
and conditions herein set forth, the Company hereby grants an option to the Underwriters, severally and not jointly, to purchase up to $9,750,000 aggregate principal amount of Option Securities at a price equal to the Purchase Price referred to in
Section 2(a) above (without giving effect to any accrued interest from the Closing Date referred to in Section 2(c) hereof to the relevant Option Closing Date, as defined below) (the “
Option Purchase Price
”). The option
hereby granted will expire at 11:59 P.M. (New York City
- 19 -
time) on the 30th day after the date hereof and may be exercised in whole or in part from time to time only for the purpose of covering over-allotments which may be made in connection with the
offering and distribution of the Initial Securities upon notice by the Representatives to the Company setting forth the aggregate principal amount of Option Securities as to which the several Underwriters are then exercising the option and the time
and date of payment and delivery for such Option Securities. Any such time and date of delivery (an “
Option Closing Date
”) shall be determined by the Representatives, but shall not be later than seven full business days after the
exercise of said option (unless postponed in accordance with the provisions of Section 10), nor in any event prior to the Closing Date. If the option is exercised as to all or any portion of the Option Securities, the Company will sell to the
Underwriters that proportion of the total aggregate principal amount of Option Securities then being purchased which the aggregate principal amount of Option Securities set forth in Section 2(b), and each of the Underwriters, acting severally
and not jointly, will purchase that proportion of the total aggregate principal amount of Option Securities then being purchased which the aggregate principal amount of Initial Securities set forth in Exhibit A opposite the name of such Underwriter,
plus any additional aggregate principal amount of Initial Securities which such Underwriter may become obligated to purchase pursuant to the provisions of Section 10 hereof, bears to the total aggregate principal amount of Initial Securities.
(c)
Payment
. Payment of the Purchase Price for, and delivery of, the Initial Securities shall be made at the offices of Fried
Frank, One New York Plaza, New York, New York 10004, or at such other place as shall be agreed upon by the Representatives and the Company, at 10:00 A.M. (New York City time) on July 14, 2017 (unless postponed in accordance with the
provisions of Section 10), or such other time not later than five business days after such date as shall be agreed upon by the Representatives and the Company (such time and date of payment and delivery being herein called “
Closing
Date
”).
In addition, in the event that any or all of the Option Securities are purchased by the Underwriters, payment of the
Option Purchase Price for, and delivery of, such Option Securities shall be made at the above-mentioned offices at 10:00 A.M. (New York City time), or at such other place as shall be agreed upon by the Representatives and the Company, on each Option
Closing Date as specified in the notice from the Representatives to the Company.
Payment shall be made to the Company by wire transfer of
immediately available funds to a single bank account designated by the Company, against delivery to the Representatives through the facilities of DTC for the respective accounts of the Underwriters of the Securities to be purchased by them. It is
understood that each Underwriter has authorized the Representatives, for its account, to accept delivery of, receipt for, and make payment of the Purchase Price for the Initial Securities and the Option Purchase Price for the Option Securities, if
any, which it has agreed to purchase. Keefe, Bruyette & Woods, Inc., Morgan Stanley & Co. LLC and Deutsche Bank Securities Inc., individually and not as Representatives of the Underwriters, may (but shall not be obligated to) make
payment of the Purchase Price for the Initial Securities or the Option Purchase Price for the Option Securities, if any, to be purchased by any Underwriter whose funds have not been received by the Closing Date or the relevant Option Closing Date,
as the case may be, but such payment shall not relieve such Underwriter from its obligations hereunder.
- 20 -
The Initial Securities and the Option Securities, if any, shall be in $25 denominations and
registered in such names as the Representatives may request in writing at least one full business day before the Closing Time or the relevant Option Closing Date, as the case may be. The Initial Securities and the Option Securities, if any, will be
made available for examination and packaging by the Representatives in The City of New York not later than 10:00 A.M. (New York City time) on the business day prior to the Closing Date or the relevant Option Closing Date, as the case may be.
(d)
Delivery of Securities
.
Delivery of the Initial Securities and any Option Securities shall be made through the
facilities of DTC unless the Representatives shall otherwise instruct.
SECTION 3.
Covenants
. Each of the Company, the Adviser
and the Administrator covenants, jointly and severally, with each Underwriter as follows:
(a)
Compliance with Securities Regulations
and Commission Requests
.
Prior to the termination of the offering of the Securities, subject to Section 3(b), to comply with the requirements of Rule 430C and will promptly notify the Representatives, and confirm the notice in
writing, (i) when the Registration Statement, any Rule 462(b) Registration Statement or any post-effective amendment to the Registration Statement shall be declared or become effective, or when any Preliminary Prospectus, the
Prospectus or any Rule 482 Material or any amendment or supplement to any of the foregoing shall have been filed, (ii) of the receipt of any comments from the Commission relating to the Registration Statement (and shall promptly furnish the
Representatives with a copy of any comment letters and any transcript of oral comments, and shall furnish the Representatives with copies of any written responses thereto a reasonable amount of time prior to the proposed filing thereof with the
Commission and will not file any such response to which the Representatives or counsel for the Underwriters shall reasonably object), (iii) of any request by the Commission for any amendment to the Registration Statement or any amendment or
supplement to any Preliminary Prospectus or the Prospectus, any Rule 482 Material or for additional information, (iv) of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or of any order
preventing or suspending the use of any Preliminary Prospectus, the Prospectus or any Rule 482 Material or any amendment or supplement to any of the foregoing, or any notice from the Commission objecting to the use of the form of the Registration
Statement or any post-effective amendment thereto, or of the suspension of the qualification of the Securities for offering or sale in any jurisdiction or of the loss or suspension of any exemption from any such qualification, or of the initiation
or threatening of any proceedings for any of such purposes, or of any examination pursuant to Section 8(e) of the 1933 Act concerning the Registration Statement, (v) if the Company becomes the subject of a proceeding under Section 8A
of the 1933 Act in connection with the offering of the Securities, and (vi) if the Company ceases to be an EGC at any time prior to the later of (A) completion of the distribution of the Securities within the meaning of the 1933 Act and
(B) completion of the Lock-Up Period referred to in Section 3(j) hereof. The Company will make every reasonable effort to prevent the issuance of any stop order and the suspension or loss of any qualification of the Securities for offering
or sale and any loss or suspension of any exemption from any such qualification, and if any such stop order is issued, or any such suspension or loss occurs, to obtain the lifting thereof at the earliest possible moment.
- 21 -
(b)
Filing of Amendments
.
Prior to the termination of the offering of the
Securities, to give the Representatives notice of its intention to file or prepare any amendment to the Registration Statement, any Rule 462(b) Registration Statement, any Rule 482 Material or any amendment, supplement or revision to any Preliminary
Prospectus, the Prospectus or any Rule 482 Material, whether pursuant to the 1933 Act or otherwise, and the Company will furnish the Representatives with copies of any such documents within a reasonable amount of time prior to such proposed filing
or use, as the case may be, and will not file or use any such document to which the Representatives or counsel for the Underwriters shall promptly and reasonably object.
(c)
Delivery of Registration Statements
.
To furnish or deliver to the Representatives and counsel for the Underwriters, without
charge, copies of the conformed Registration Statement and any Rule 462(b) Registration Statement and of each amendment thereto (including exhibits filed therewith or incorporated by reference therein and documents incorporated by
reference therein
)
and copies of all consents and certificates of experts.
(d)
Delivery of Prospectuses
.
To deliver
to each Underwriter, without charge, as many copies of each Preliminary Prospectus and any amendments or supplements thereto as such Underwriter reasonably requested, and the Company hereby consents to the use of such copies for purposes permitted
by the 1933 Act. The Company will furnish to each Underwriter, without charge, during the period when the Prospectus is required (or, but for the provisions of Rule 172, would be required) to be delivered by applicable law (whether to meet the
request of purchasers pursuant to Rule 173(d) or otherwise), such number of copies of the Pre-Pricing Prospectus, the Prospectus and any Rule 482 Material and any amendments or supplements to any of the foregoing as such Underwriter
may reasonably request; and in case any Underwriter is required to deliver a prospectus in connection with sales of any of the Securities at any time nine months or more after the time of issue of the Prospectus, upon your request but at the expense
of such Underwriter, to prepare and deliver to such Underwriter as many written and electronic copies as you may request of an amended or supplemented Prospectus complying with Section 10(a)(iii) of the 1933 Act.
(e)
Continued Compliance with Securities Laws
.
To comply with the 1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act
Regulations, the 1940 Act, the 1940 Act Regulations and the 1939 Act so as to permit the completion of the distribution of the Securities as contemplated by this Agreement, the General Disclosure Package and the Prospectus. If at any time when a
prospectus is required (or, but for the provisions of Rule 172, would be required) by the 1933 Act to be delivered in connection with sales of the Securities (whether to meet the request of purchasers pursuant to Rule 173(d) or otherwise), any event
shall occur or condition shall exist as a result of which it is necessary (or if the Representatives or counsel for the Underwriters shall notify the Company that, in their reasonable judgment, it is necessary) to amend the Registration Statement or
amend or supplement the General Disclosure Package or the Prospectus so that the Registration Statement, the General Disclosure Package or the Prospectus, as the case may be, will not include any untrue statement of a material fact or omit to state
a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made or then prevailing, not misleading or if it is necessary (or if the Representatives or counsel for the Underwriters shall
notify the Company that, in their reasonable judgment, it is necessary) to amend the Registration Statement or amend or supplement the General Disclosure Package or the Prospectus in order to comply with the
- 22 -
requirements of the 1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act Regulations, the 1940 Act, the 1940 Act Regulations or the 1939 Act, the Company will promptly notify the
Representatives of such event or condition and of its intention to file such amendment or supplement (or, if the Representatives or counsel for the Underwriters shall have notified the Company as aforesaid, the Company will promptly notify the
Representatives of its intention to prepare such amendment or supplement) and will promptly prepare and file with the Commission, subject to Section 3(b) hereof, such amendment or supplement as may be necessary to correct such untrue statement
or omission or to comply with such requirements, and, in the case of an amendment or post-effective amendment to the Registration Statement, the Company will use its best efforts to have such amendment declared or become effective as soon as
practicable, and the Company will furnish to the Underwriters such number of copies of such amendment or supplement as the Underwriters may reasonably request. If at any time any Rule 482 Material conflicts with the information contained in the
Registration Statement or if an event shall occur or condition shall exist as a result of which it is necessary (or, if the Representatives or counsel for the Underwriters shall notify the Company that, in their reasonable judgment, it is necessary)
to amend or supplement such Rule 482 Material so that it will not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which
they were made or then prevailing, not misleading, or if it is necessary (or, if the Representatives or counsel for the Underwriters shall notify the Company that, in their reasonable judgment, it is necessary) to amend or supplement such Rule 482
Material in order to comply with the requirements of the 1933 Act or the 1933 Act Regulations, the Company will promptly notify the Representatives of such event or condition and of its intention to file such amendment or supplement (or, if the
Representatives or counsel for the Underwriters shall have notified the Company as aforesaid, the Company will promptly notify the Representatives of its intention to prepare such amendment or supplement) and will promptly prepare and, if required
by the 1933 Act or the 1933 Act Regulations, file with the Commission, subject to Section 3(b) hereof, such amendment or supplement as may be necessary to eliminate or correct such conflict, untrue statement or omission or to comply with such
requirements, and the Company will furnish to the Underwriters such number of copies of such amendment or supplement as the Underwriters may reasonably request.
(f)
Blue Sky and Other Qualifications
.
To use commercially reasonable efforts, in cooperation with the Underwriters, to qualify
the Securities for offering and sale, or to obtain an exemption for the Securities to be offered and sold, under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Representatives may designate and to
maintain such qualifications and exemptions in effect for so long as required for the distribution of the Securities (but in no event for less than one year from the date of this Agreement);
provided
,
however
,
that
the Company
shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing
business in any jurisdiction in which it is not otherwise so subject. In each jurisdiction in which the Securities have been so qualified or exempt, the Company will file such statements and reports as may be required by the laws of such
jurisdiction to continue such qualification or exemption, as the case may be, in effect for so long as required for the distribution of the Securities (but in no event for a less than one year from the date of this Agreement).
- 23 -
(g)
Rule 158
.
To timely file such reports pursuant to the 1934 Act as are necessary
in order to make generally available to its securityholders as soon as practicable an earnings statement for the purposes of, and to provide to the Underwriters the benefits contemplated by, the last paragraph of Section 11(a) of the 1933 Act.
(h)
Use of Proceeds
. To use the net proceeds received by it from the sale of the Securities in the manner specified in the
Pre-Pricing Prospectus and the Prospectus under “Use of Proceeds.”
(i)
Listing
. The Company will use its best efforts to
effect and maintain the listing of the Securities on the NYSE within 30 days of the Closing.
(j)
Restriction on Sale of
Securities
. During the Lock-Up Period, each of the Company, the Adviser and the Administrator will not, without the prior written consent of the Representatives, directly or indirectly:
(i) issue, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any
option, right or warrant to purchase, lend or otherwise transfer or dispose of any debt securities, issued or guaranteed by the Company which are substantially similar to the Securities or any securities convertible into or exercisable or
exchangeable for or repayable with debt securities issued or guaranteed by the Company which are substantially similar to the Securities or file any registration statement under the 1933 Act with respect to any of the foregoing;
(ii) enter into any swap or other agreement, arrangement, hedge or transaction that transfers to another, in whole or in part, directly or
indirectly, any of the economic consequences of ownership of any of the Company’s debt securities, including the Securities, or any securities convertible into or exercisable or exchangeable for any of the Company’s debt securities;
whether any transaction described in clause (i) or (ii) above is to be settled by delivery of the Securities or such other securities, in cash or
otherwise, other than the Securities to be sold hereunder or publicly announce any intention to do any of the foregoing.
(k)
Stabilization and Manipulation
.
To not take, directly or indirectly, any action designed to or that would constitute or that might reasonably be expected to cause or result in, under the 1934 Act or otherwise, stabilization or
manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities.
(l)
Stockholder
Communications
. To, for a period of one year following the date hereof, furnish to the Representatives all reports or other communications (financial or other) generally made available to stockholders, and deliver such reports and communications
to the Representatives as soon as they are available, unless such documents are furnished to or filed with the Commission or any securities exchange on which any class of securities of the Company is listed and generally made available to the
public,
provided that
such filings shall be considered furnished to the Representatives for purposes of this section upon filing pursuant to the EDGAR system.
- 24 -
(m)
Securities Laws, Rules and Regulations
. To comply with all applicable
securities and other applicable laws, rules and regulations, including, without limitation, the Sarbanes-Oxley Act, and will use their best reasonable efforts to cause the Company’s, the Adviser’s and the Administrator’s directors and
officers, in their capacities as such, to comply with such laws, rules and regulations, including, without limitation, the provisions of the Sarbanes-Oxley Act.
(n)
Fidelity Bond
. To be insured by insurers of recognized financial responsibility against such losses and risks and in such
amounts as are prudent and customary in the businesses in which they are engaged; all policies of insurance and fidelity or surety bonds insuring the Company, the Adviser, the Administrator or their respective businesses, properties, assets,
employees, officers, trustees, directors, members, managers and partners will be in full force and effect; the Company, the Adviser and the Administrator will be in compliance with the terms of such policies and instruments.
(o)
RIC Status
. To use its best efforts to maintain its qualification and election as a RIC in effect for each taxable year
during which it is a BDC under the 1940 Act.
(p)
BDC Status
. During a period of two years from the effective date of
the Registration Statement, to use its best efforts to maintain its status as a BDC; provided, however, that the Company may change the nature of its business so as to cease to be, or to withdraw its election as, a BDC, with the approval of the
board of directors and a vote of stockholders as required by Section 58 of the 1940 Act or any successor provision.
(q)
Transfer Agent
. To maintain a transfer agent and, if necessary under the jurisdiction of incorporation of the Company, a
registrar for the Company’s common stock.
(r)
Distribution of the Securities
. To comply with the 1933 Act, the
1933 Act Regulations, the 1934 Act, the 1934 Act Regulations, the 1940 Act, the 1940 Act Regulations and the 1939 Act, so as to permit the completion of the distribution of the Securities as contemplated in this Agreement, the General Disclosure
Package and the Prospectus.
(s)
Performance of Agreements and Discharge to Conditions
. To use the Company’s,
the Adviser’s and the Administrator’s best reasonable efforts to perform all of the agreements required of them by this Agreement and discharge all conditions of theirs to closing as set forth in this Agreement.
(t)
Reporting Requirements
. During the period when the Prospectus is required (or, but for the provisions of Rule 172, would be
required) by the 1933 Act, 1934 Act and the Rules and Regulations to be delivered (whether to meet the request of purchasers pursuant to Rule 173(d) or otherwise), to file all documents required to be filed with the Commission pursuant to the
1934 Act and the 1934 Act Regulations within the time periods required by the 1934 Act and the 1934 Act Regulations.
(u)
Preparation of Prospectus
. Immediately following the execution of this Agreement, subject to Section 3(a) hereof, to prepare the Prospectus, which shall contain the selling terms of the Securities, the plan of distribution thereof and
such other information as may be required by the 1933 Act or the 1933 Act Regulations or as the Representatives and the Company may reasonably deem appropriate and will file or transmit for filing with the Commission the Prospectus in accordance
with the provisions of Rule 430C and in the manner and within the time period required by Rule 497.
- 25 -
SECTION 4.
Payment of Expenses.
(a)
Expenses
. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including
(i) the preparation, printing and filing of the Registration Statement and each amendment or supplement thereto (in each case including exhibits) and any costs associated with electronic delivery of any of the foregoing, (ii) the word
processing and delivery to the Underwriters of this Agreement, the Indenture and such other documents as may be required in connection with the offering, purchase, sale, issuance or delivery of the Securities, (iii) the preparation, issuance
and delivery of the Securities to be sold by the Company to the Underwriters, including any stock or other transfer taxes and any stamp or other taxes or duties payable in connection with the sale, issuance or delivery of the Securities to the
Underwriters, (iv) the fees and disbursements of the counsel, accountants and other advisers to the Company, (v) the qualification or exemption of the Securities under securities laws in accordance with the provisions of Section 3(f)
hereof, including filing fees and the reasonable fees and disbursements of counsel for the Underwriters in connection therewith and in connection with the preparation of the Blue Sky Survey and any supplements thereto, (vi) the preparation,
printing and delivery to the Underwriters of copies of the Registration Statement, any Preliminary Prospectus and the Prospectus, any Sales Material and any amendments or supplements to any of the foregoing, in each case, as may be reasonably
requested, and any costs associated with electronic delivery of any of the foregoing, (vii) the preparation, printing and delivery to the Underwriters of copies of the Blue Sky Survey and any Canadian “wrapper” and any supplements
thereto and any costs associated with electronic delivery of any of the foregoing, (viii) the fees and expenses of the trustee, paying agent and registrar for the Securities, (ix) the filing fees incident to, and the reasonable fees and
disbursements of counsel to the Underwriters in connection with, the review, if any, by FINRA of the terms of the sale of the Securities, (x) the fees and expenses incurred in connection with the listing of the Securities on NYSE, and
(xi) the costs and expenses of the Company and any of its officers, directors, counsel or other Representatives in connection with presentations or meetings undertaken in connection with the offering of the Securities, including, without
limitation, expenses associated with the production of road show slides and graphics and the production and hosting of any electronic road shows, fees and expenses of any consultants engaged in connection with road show presentations, and travel,
lodging, transportation, and other expenses of the officers, directors, counsel and other Representatives of the Company incurred in connection with any such presentations or meetings.
(b)
Termination of Agreement
. If this Agreement is terminated by the Representatives prior to the Closing Date in accordance with the
provisions of Sections 5, 9(a)(i), 9(a)(ii) or 9(a)(iv)(A) hereof, the Company shall reimburse the Underwriters for all of their out-of-pocket expenses, including the reasonable fees and disbursements of counsel for the Underwriters.
SECTION 5.
Conditions of Underwriters’ Obligations.
The obligations of the several Underwriters hereunder are subject to the
accuracy of the representations and warranties of the Company, the Adviser and the Administrator contained in this Agreement, or in certificates
- 26 -
signed by any officer of the Company, the Adviser or the Administrator (whether signed on behalf of such officer or the Company, the Adviser or the Administrator) delivered to the Representatives
or counsel for the Underwriters, to the performance by the Company of its respective covenants and other obligations hereunder, and to the following further conditions:
(a)
Effectiveness of Registration Statement
. The Registration Statement has been declared effective, any Rule 462(b)
Registration Statement has become effective, and no stop order suspending the effectiveness of the Registration Statement or any Rule 462(b) Registration Statement shall have been issued under the 1933 Act or proceedings therefor initiated or, to
the knowledge of the Company, threatened by the Commission, and any request on the part of the Commission for additional information shall have been complied with to the reasonable satisfaction of the Representatives and the Commission shall not
have notified the Company of any objection to the use of the form of the Registration Statement. The Prospectus shall have been filed with the Commission pursuant to Rule 497 under the 1933 Act within the applicable time period prescribed for such
filing by the 1933 Act Regulations; the Registration Statement shall be effective and no stop order suspending or preventing the use of the Registration Statement, any Preliminary Prospectus or the Prospectus shall have been initiated or, to the
Company’s knowledge, threatened by the Commission; and all requests for additional information on the part of the Commission shall have been complied with to the Representatives’ reasonable satisfaction.
(b)
Opinion of Counsel for the Company
. At the Closing Date, the Representatives shall have received the favorable opinions,
each dated as of the Closing Date, of Eversheds Sutherland (US) LLP, counsel for the Company (“
Company Counsel
”), in form and substance satisfactory to the Representatives, together with signed or reproduced copies of such opinion
for each of the other Underwriters, to the effect set forth in Exhibit C hereto and to such further effect as the Representatives may reasonably request.
(c)
Opinion of Counsel for the Underwriters
. At the Closing Date, the Representatives shall have received the favorable opinion,
dated as of the Closing Date, of Fried Frank, counsel for the Underwriters (“
Underwriters’ Counsel
”), together with signed or reproduced copies of such opinion for each of the other Underwriters, with respect to the Securities
to be sold by the Company pursuant to this Agreement, this Agreement, the Registration Statement, any Rule 462(b) Registration Statement, the General Disclosure Package and the Prospectus and any amendments or supplements thereto and such other
matters as the Representatives may reasonably request.
(d)
No Material Adverse Change
. At the Closing Date or the
applicable Option Closing Date, as the case may be, there shall not have been, since the date hereof or since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package and the Prospectus (in
each case exclusive of any amendments or supplements thereto subsequent to the date of this Agreement), any material adverse change or any development that could be expected to result in a material adverse change, in the condition (financial or
other), results of operations, business, properties, management or business prospects of the Company, the Adviser and the Administrator whether or not arising in the ordinary course of business.
- 27 -
(e)
Officers’ Certificates
. At the Closing Date, the Representatives shall
have received certificates, signed on behalf of each of the Company, the Adviser and the Administrator by the President or the Chief Executive Officer of the Company, the Adviser and the Administrator, as applicable, and the Chief Financial Officer
or Chief Accounting Officer of the Company, the Adviser and the Administrator, as applicable, to the effect that (i) there has been no such material adverse change in the condition (financial or other), results of operations, business,
properties, management or business prospects of the Company, the Adviser and the Administrator, as applicable, (ii) the representations and warranties of the Company, the Adviser and the Administrator, as applicable, in this Agreement are true
and correct at and as of the Closing Date with the same force and effect as though expressly made at and as of the Closing Date, (iii) each of the Company, the Adviser and the Administrator has complied with all agreements and satisfied all
conditions on its part to be performed or satisfied at or prior to the Closing Date under or pursuant to this Agreement, and (iv) no stop order suspending the effectiveness of the Registration Statement has been issued and no proceedings for
that purpose have been instituted or are pending or, to the knowledge of the Company, are contemplated by the Commission and the Commission has not notified the Company of any objection to the use of the form of the Registration Statement.
(f)
Accountant’s Comfort Letter
. At the time of the execution of this Agreement, the Representatives and the
Company’s board of directors shall have received from Deloitte & Touche LLP a letter, dated the date of this Agreement and in form and substance satisfactory to the Representatives, together with signed or reproduced copies of such
letter for each of the other Underwriters, containing statements and information of the type ordinarily included in accountants’ “comfort letters” to underwriters with respect to the financial statements and certain financial
information of the Company contained in the Registration Statement, the General Disclosure Package and the Prospectus and any amendments or supplements to any of the foregoing.
(g)
Bring-down Comfort Letter
. At the Closing Date, the Representatives and the Company’s board of directors shall have
received from Deloitte & Touche LLP a letter, dated as of the Closing Date and in form and substance satisfactory to the Representatives, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection
(f) of this Section, except that the specified date referred to shall be a date not more than three business days prior to the Closing Date.
(h)
Indenture
. At or prior to the Closing Date, the Company and the Trustee shall have executed and delivered the Second
Supplemental Indenture.
(i)
DTC
. The Securities will be eligible for clearance through DTC.
(j)
No Objection
. Prior to the date of this Agreement, FINRA shall have confirmed in writing that it has no objection with
respect to the fairness and reasonableness of the underwriting terms and arrangements.
(k)
No Crisis
. On or after the
Applicable Time there shall not have occurred any of the following: (i) a suspension or material limitation in trading in securities generally on the NYSE, NASDAQ Global Market or NASDAQ Capital Market; (ii) a suspension or material
- 28 -
limitation in trading in the Company’s securities on the NYSE; (iii) a general moratorium on commercial banking activities declared by any of Federal, Delaware or New York State
authorities or a material disruption in commercial banking or securities settlement or clearance services in the United States; (iv) the outbreak or escalation of hostilities involving the United States or the declaration by the United States
of a national emergency or war or (v) the occurrence of any other calamity or crisis or any change in financial, political or economic conditions in the United States or elsewhere, if the effect of any such event specified in clause (iv)
or (v) in the judgment of the Representative makes it impracticable or inadvisable to proceed with the public offering or the delivery of the Securities being delivered at such Closing Date or Option Closing Date, as the case may be, on the
terms and in the manner contemplated in the Prospectus.
(l)
Conditions to Purchase of Option Securities
. In the event that
the Underwriters exercise their option provided in Section 2(b) hereof to purchase all or any portion of the Option Securities on any Option Closing Date that is after the Closing Date, the obligations of the several Underwriters to purchase
the applicable Option Securities shall be subject to the conditions specified in the introductory paragraph of this Section 5 and to the further condition that, at the applicable Option Closing Date, the Representatives shall have received:
(i)
Opinion of Counsel for Company
. The favorable opinion of each Company Counsel in form and substance satisfactory to
the Representatives and dated such Option Closing Date, relating to the Option Securities to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section 5(b) hereof.
(ii)
Opinion of Counsel for Underwriters
. The favorable opinion of Underwriters’ Counsel, in form and substance
satisfactory to the Representatives and dated such Option Closing Date, relating to the Option Securities to be purchased on such Option Closing Date and otherwise to the same effect as the opinion required by Section 5(c) hereof.
(iii)
Officers’ Certificates
. Certificates, dated such Option Closing Date, to the effect set forth in, and signed on
behalf of the Company, the Adviser and the Administrator by the officers specified in, Section 5(e) hereof, except that the references in such certificate to the Closing Date shall be changed to refer to such Option Closing Date.
(iv)
Bring-down Comfort Letter
. A letter from Deloitte & Touche LLP, in form and substance satisfactory to the
Representatives and dated such Option Closing Date, substantially in the same form and substance as the letter furnished to the Representatives pursuant to Section 5(g) hereof, except that the specified date in the letter furnished
pursuant to this paragraph shall be a date not more than three business days prior to such Option Closing Date, and except that such letter shall also cover any amendments or supplements to the Registration Statement and the Prospectus subsequent to
the Closing Date.
(m)
Additional Documents
. At the Closing Date and each Option Closing Date, counsel for the Underwriters
shall have been furnished with such documents and opinions as they may reasonably require for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in order to evidence the accuracy of any of
the representations or warranties, or the fulfillment of any of the conditions, contained in this
- 29 -
Agreement, or as the Representatives or counsel for the Underwriters may otherwise reasonably request; and all proceedings taken by the Company in connection with the issuance and sale of the
Securities as herein contemplated and in connection with the other transactions contemplated by this Agreement shall be satisfactory in form and substance to the Representatives.
(n)
Termination of Agreement
. If any condition specified in this Section 5 shall not have been fulfilled when and as
required to be fulfilled, this Agreement, or, in the case of any condition to the purchase of Option Securities on an Option Closing Date which is after the Closing Date, the obligations of the several Underwriters to purchase the relevant Option
Securities on such Option Closing Date, may be terminated by the Representatives by notice to the Company at any time on or prior to Closing Date or such Option Closing Date, as the case may be, and such termination shall be without liability of any
party to any other party except as provided in Section 4 hereof and except that, in the case of any such termination of this Agreement, Sections 1, 6, 7, 8, 11, 12, 13, 14, 15, 16, 17, 18 and 19 hereof shall survive such termination of this
Agreement and remain in full force and effect.
SECTION 6.
Indemnification.
(a)
Indemnification by the Company
. The Company, the Adviser and the Administrator, jointly and severally, agree to indemnify
and hold harmless each Underwriter, its affiliates, and its officers, directors, employees, partners and members and each person, if any, who controls any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of the
1934 Act as follows:
(i) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, arising out of any
untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make
the statements therein not misleading, or arising out of any untrue statement or alleged untrue statement of a material fact included in any Preliminary Prospectus, any Sales Material, any Rule 482 Material, the General Disclosure Package or
the Prospectus (or any amendment or supplement to any of the foregoing) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made,
not misleading; and
(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred, to the extent of the
aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission, or any such alleged
untrue statement or omission;
provided that
(subject to Section 6(e) below) any such settlement is effected with the written consent of the Company; and
(iii) against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel chosen by the Representatives),
reasonably incurred in investigating, preparing for or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue statement or
omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i) or (ii) above;
- 30 -
provided
,
however
,
that
this indemnity agreement shall not apply to any loss, liability,
claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Company by any Underwriter through the
Representatives expressly for use in the Registration Statement (or any amendment thereto), or in any Preliminary Prospectus, the General Disclosure Package or the Prospectus (or in any amendment or supplement to any of the foregoing), it being
understood and agreed that the only such information furnished by the Underwriters as aforesaid consists of the information described as such in Section 6(b) hereof.
(b)
Indemnification by the Underwriters
. Each Underwriter agrees, severally and not jointly, to indemnify and hold harmless the
Company, the Adviser and the Administrator, each of their directors, affiliates, officers, employees, partners and members, and each person, if any, who controls the Company, the Adviser or the Administrator within the meaning of Section 15 of
the 1933 Act or Section 20 of the 1934 Act against any and all loss, liability, claim, damage and expense described in the indemnity contained in subsection (a) of this Section 6, as incurred, but only with respect to untrue
statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendment thereto), or in any Preliminary Prospectus, Rule 482 Material, the General Disclosure Package or the Prospectus (or any
amendment or supplement to any of the foregoing), in reliance upon and in conformity with written information furnished to the Company by such Underwriter through the Representatives expressly for use therein. The Company hereby acknowledges and
agrees that the information furnished to the Company by the Underwriters through the Representatives expressly for use in the Registration Statement (or any amendment thereto), or in any Preliminary Prospectus, Rule 482 Material, the General
Disclosure Package or the Prospectus (or any amendment or supplement to any of the foregoing), consists exclusively of the following: (i) the names of the Underwriters and principal business addresses of the Representatives and (ii) the
information regarding price stabilizations and short positions appearing in the “Pricing Stabilization, Short Positions” section under the caption “Underwriting” in the Pre-Pricing Prospectus and the Prospectus.
(c)
Actions Against Parties; Notification
. Each indemnified party shall give notice as promptly as reasonably practicable to each
indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder. Counsel to the
indemnified parties shall be selected as follows: counsel to the Underwriters and the other indemnified parties referred to in Section 6(a) above shall be selected by the Representatives, and counsel to the Company, the Adviser, the
Administrator, each of their directors, affiliates, officers, employees, partners and members and each person, if any, who controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall be
selected by the Company, the Adviser and the Administrator. An indemnifying party may participate at its own expense in the defense of any such action;
provided
,
however
,
that
counsel to the indemnifying party shall not (except
with the consent of the indemnified party) also be counsel to the indemnified party. In no event shall the indemnifying parties be liable for the fees and expenses of more than one counsel (in addition to
- 31 -
any local counsel) separate from their own counsel for the Underwriters and the other indemnified parties referred to in Section 6(a)(i) above and the fees and expenses of more than one
counsel (in addition to any local counsel) separate from their own counsel for the Company, the Adviser, the Administrator each of their directors, affiliates, officers, employees, partners and members and each person, if any, who controls the
Company, the Adviser or the Administrator within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act, in each case in connection with any one action or separate but similar or related actions in the same jurisdiction
arising out of the same general allegations or circumstances. No indemnifying party shall, without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or
any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of which indemnification or contribution could be sought under this Section 6 or Section 7 hereof (whether or
not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising out of such litigation,
investigation, proceeding or claim and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party.
(d)
Settlement Without Consent if Failure to Reimburse
. If at any time an indemnified party shall have requested an indemnifying
party to reimburse the indemnified party for fees and expenses of counsel as contemplated by this Section 6, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by
Section 6(a)(ii) effected without its written consent if (i) such settlement is entered into more than 60 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received
notice of the terms of such settlement at least 60 days prior to such settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such
settlement.
(e)
Other Agreements with Respect to Indemnification and Contribution
. The provisions of this
Section 6 and in Section 7 hereof shall not affect any agreements among the Company, the Adviser and the Administrator with respect to indemnification of each other or contribution between themselves.
(f)
1940 Act Limitations.
Any indemnification and contribution by the Company shall be subject to the requirements and
limitations of Section 17(i) of the 1940 Act.
SECTION 7.
Contribution.
If the indemnification provided for in
Section 6 hereof is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party shall contribute to the
aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, the Adviser and the
Administrator, on the one hand, and the Underwriters, on the other hand, from the offering of the Securities pursuant to this Agreement or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in such
proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company, the Adviser and the Administrator, on the one hand, and of the Underwriters, on the other
hand, in connection with the statements or omissions, which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations.
- 32 -
The relative benefits received by the Company, the Adviser and the Administrator (treated jointly
for this purpose as one person), on the one hand, and the Underwriters, on the other hand, in connection with the offering of the Securities pursuant to this Agreement shall be deemed to be in the same respective proportions as the total net
proceeds from the offering of the Securities pursuant to this Agreement (before deducting expenses) received by the Company, the Adviser and the Administrator (treated jointly for this as one person) and the total underwriting discounts and
commissions received by the Underwriters, in each case as set forth on the cover of the Prospectus, bear to the aggregate initial public offering price of the Securities as set forth on such cover.
The relative fault of the Company, the Adviser and the Administrator, on the one hand, and the Underwriters, on the other hand, shall be
determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company, the Adviser and the
Administrator, on the one hand, and the Underwriters, on the other hand, and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Company, the Adviser, the Administrator and the Underwriters agree that it would not be just and equitable if contribution pursuant
to this Section 7 were determined by
pro rata
allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to
above in this Section 7. The aggregate amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section 7 shall be deemed to include any legal or other expenses reasonably
incurred by such indemnified party in investigating, preparing for or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such
untrue or alleged untrue statement or omission or alleged omission.
Notwithstanding the provisions of this Section 7, no
Underwriter shall be required to contribute any amount in excess of the amount by which the total price at which the Securities underwritten by it and distributed to the public were offered to the public exceeds the amount of any damages which such
Underwriter has otherwise been required to pay by reason of any such untrue or alleged untrue statement or omission or alleged omission.
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the 1933 Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent misrepresentation.
For purposes of this Section 7, each affiliate
of any Underwriter, each officer, director, employee, partner and member of any Underwriter or any such affiliate, and each person, if any, who controls any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of
- 33 -
the 1934 Act shall have the same rights to contribution as such Underwriter, and each director, affiliate, officer, employee, partner and member of the Company, the Adviser or the Administrator,
and each person, if any, who controls the Company, the Adviser or the Administrator within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution as the Company, the Adviser and
the Administrator. The Underwriters’ respective obligations to contribute pursuant to this Section 7 are several in proportion to the aggregate principal amount of Initial Securities set forth opposite their respective names in
Exhibit A hereto and not joint.
SECTION 8.
Representations, Warranties and Agreements to Survive Delivery.
All
representations, warranties and agreements contained in this Agreement or in certificates signed by any officer of the Company, the Adviser or the Administrator (whether signed on behalf of such officer, the Company, the Adviser or the
Administrator) and delivered to the Representatives or counsel to the Underwriters, shall remain operative and in full force and effect, regardless of any investigation made by or on behalf of any Underwriter, any officer, director, employee,
partner, member or agent of any Underwriter or any person controlling any Underwriter, or by or on behalf of the Company, the Adviser or the Administrator any officer, director or employee of the Company or any person controlling the Company and
shall survive delivery of and payment for the Securities.
SECTION 9.
Termination of Agreement.
(a)
Termination; General
. The Representatives may terminate this Agreement, by notice to the Company, the Adviser or the Administrator,
at any time on or prior to the Closing Date (and, if any Option Securities are to be purchased on an Option Closing Date which occurs after the Closing Date, the Representatives may terminate the obligations of the several Underwriters to purchase
such Option Securities, by notice to the Company at any time on or prior to such Option Closing Date) (i) if there has been, at any time on or after the date of this Agreement or since the respective dates as of which information is given in
the General Disclosure Package or the Prospectus (in each case exclusive of any amendments or supplements thereto subsequent to the date of this Agreement), any material adverse change or any development that could reasonably be expected to result
in a material adverse change in the condition (financial or other), results of operations, business, properties, management or business prospects of the Company, whether or not arising in the ordinary course of business, or (ii) if there has
been, since the time of execution of this Agreement or since the respective dates as of which information is given in the General Disclosure Package or the Prospectus (in each case exclusive of any amendments or supplements thereto subsequent to the
date of this Agreement), any material adverse change in the condition, financial or otherwise, or in the business affairs or business prospects of the Adviser or the Administrator, whether or not arising in the ordinary course of business, or
(iii) if there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any declaration of a national emergency or war by the United States, any outbreak of hostilities or
escalation thereof or other calamity or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions (including, without limitation, as a result of terrorist activities),
in each case the effect of which is such as to make it, in the judgment of the Representatives, impracticable or inadvisable to market the Securities or to enforce contracts for the sale of the Securities, (iv) if (A) trading in any
securities of the Company has been
- 34 -
suspended or materially limited by the Commission or NYSE, or (B) trading generally on the NYSE or the Nasdaq Global Select Market has been suspended or materially limited, or minimum or
maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any of said exchanges or by order of the Commission, FINRA or any other governmental authority, or (C) a material disruption has occurred in
commercial banking or securities settlement or clearance services in the United States or, (v) if a banking moratorium has been declared by either Federal or New York authorities.
(b)
Liabilities
. If this Agreement is terminated pursuant to this Section 9, such termination shall be without liability of
any party to any other party except as provided in Section 4 hereof and except that Sections 1, 6, 7, 8, 11, 12, 13, 14, 15, 16, 17, 18 and 19 hereof shall survive such termination and remain in full force and effect.
SECTION 10.
Default by One or More of the Underwriters.
If one or more of the Underwriters shall fail at the Closing Date or an Option Closing Date to purchase the Securities which it or they are
obligated to purchase under this Agreement (the “
Defaulted Securities
”), the Representatives shall have the right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting Underwriters, or any
other underwriters, to purchase all, but not less than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the Representatives shall not have completed such arrangements within
such 24-hour period, then:
(i) if the aggregate principal amount of Defaulted Securities does not exceed 10% of the aggregate principal
amount of Securities to be purchased on such date, each of the non-defaulting Underwriters shall be obligated, severally and not jointly, to purchase the full amount of such Defaulted Securities in the proportions that their respective underwriting
obligations hereunder bear to the underwriting obligations of all non-defaulting Underwriters; or
(ii) if the aggregate principal amount
of Defaulted Securities exceeds 10% of the aggregate principal amount of Securities to be purchased on such date, this Agreement or, with respect to any Option Closing Date which occurs after the Closing Date, the obligation of the Underwriters to
purchase and of the Company to sell the Option Securities that were to have been purchased and sold on such Option Closing Date, shall terminate without liability on the part of any non-defaulting Underwriter.
No action taken pursuant to this Section 10 shall relieve any defaulting Underwriter from liability in respect of its default.
In the event of any such default which does not result in a termination of this Agreement or, in the case of an Option Closing Date which is
after the Closing Date, which does not result in a termination of the obligations of the Underwriters to purchase and the Company to sell the relevant Option Securities, as the case may be, the Representatives shall have the right to postpone the
Closing Date or the relevant Option Closing Date, as the case may be, for a period not exceeding seven days in order to effect any required changes in the Registration Statement, the General Disclosure Package or Prospectus or in any other documents
or arrangements. As used herein, the term “Underwriter” includes any person substituted for an Underwriter under this Section 10.
- 35 -
SECTION 11.
Notices.
All notices and other communications hereunder shall be in
writing, shall be effective only upon receipt and shall be mailed, delivered by hand or overnight courier, or transmitted by fax (with the receipt of such fax to be confirmed by telephone). Notices to the Underwriters shall be directed to the
Representatives at c/o Keefe, Bruyette & Woods, Inc., 787 Seventh Avenue, New York, New York, 10019; Morgan Stanley & Co. LLC, 1585 Broadway, New York, New York 10036; and Deutsche Bank Securities Inc., 60 Wall Street, New York,
New York 10005, attention: Debt Capital Markets Syndicate, with a copy to General Counsel (Fax: (212) 797-4561). Copies of all such notices should be sent to Fried, Frank, Harris, Shriver & Jacobson LLP, One New York Plaza, New York,
New York 10004, Attention: Stuart Gelfond. Notices to the Company, the Adviser and/or the Administrator shall be directed to it at TriplePoint Venture Growth BDC Corp., 2755 Sand Hill Road Suite 150, Menlo Park, California 94025, Attention:
Sajal Srivastava, fax no. 650-854-2092 (with such fax to be confirmed by telephone), and copies of all such notices should be sent to Eversheds Sutherland (US) LLP, 700 Sixth Street NW, Suite 700, Washington, DC 20001, Attention: Harry S. Pangas.
In accordance with the requirements of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the
Underwriters are required to obtain, verify and record information that identifies their respective clients, including the Company, which information may include the name and address of their respective clients, as well as other information that
will allow the Underwriters to properly identify their respective clients.
SECTION 12.
Parties.
This Agreement shall each
inure to the benefit of and be binding upon the Underwriters, the Company, the Adviser, the Administrator and their respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or
corporation, other than the Underwriters, the Company, the Adviser, the Administrator and their respective successors and the controlling persons and other indemnified parties referred to in Sections 6 and 7 and their successors, heirs and
legal Representatives, any legal or equitable right, remedy or claim under or in respect of this Agreement or any provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive
benefit of the Underwriters, the Company, the Adviser, the Administrator and their respective successors, and said controlling persons and other indemnified parties and their successors, heirs and legal Representatives, and for the benefit of no
other person or entity. No purchaser of Securities from any Underwriter shall be deemed to be a successor by reason merely of such purchase.
SECTION 13.
GOVERNING LAW AND TIME
. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF
NEW YORK. EXCEPT AS OTHERWISE EXPRESSLY SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME.
SECTION 14.
Effect
of Headings
The Section and Exhibit headings herein are for convenience only and shall not affect the construction hereof.
- 36 -
SECTION 15.
Definitions
As used in this Agreement, the following terms have the
respective meanings set forth below:
“
1933 Act
” means the Securities Act of 1933, as amended.
“
1933 Act Regulations
” means the rules and regulations of the Commission under the 1933 Act.
“
1934 Act
” means the Securities Exchange Act of 1934, as amended.
“
1934 Act Regulations
” means the rules and regulations of the Commission under the 1934 Act.
“
1940 Act
” means the Investment Company Act of 1940, as amended.
“
1940 Act Notification
” shall mean the Company’s notification of election to be regulated as a BDC under the 1940 Act on
Form N-54A, as the 1940 Act Notification may be amended from time to time.
“
1940 Act Regulations
” means the
rules and regulations of the Commission under the 1940 Act.
“
Administrator Document
” means any contracts,
indentures, mortgages, deeds of trust, loan or credit agreements, bonds, notes, debentures, evidence of indebtedness, leases or other instruments or agreements to which the Administrator is a party or by which the Administrator is bound or to which
any of the property or assets of the Administrator is subject.
“
Advisers Act
” shall mean the Investment Advisers Act of
1940, as amended.
“
Advisers Act Regulations
” shall mean the rules and regulations of the Commission under the
Advisers Act.
“
Adviser Document
” means any contracts, indentures, mortgages, deeds of trust, loan or credit agreements,
bonds, notes, debentures, evidence of indebtedness, leases or other instruments or agreements to which the Adviser is a party or by which the Adviser is bound or to which any of the property or assets of the Adviser is subject.
“
Applicable Time
” means 4:45 P.M. (New York City time) on July 11, 2017 or such other time as agreed by the Company and
the Representatives.
“
Base Prospectus
” means the prospectus included in the Registration Statement as of the Effective
Date.
“
Code
” means the Internal Revenue Code of 1986, as amended.
“
Commission
” means the Securities and Exchange Commission.
“
Common Stock
” shall have the meaning as defined in Section 1(a)(x) of this Agreement.
- 37 -
“
Company Documents
” means any contracts, indentures, mortgages, deeds of trust,
loan or credit agreements, bonds, notes, debentures, evidences of indebtedness, leases or other instruments or agreements to which the Company is a party or by which the Company is bound or to which any of the property or assets of the Company is
subject including, all Subject Instruments and the formation agreements.
“
DTC
” means The Depository Trust Company.
“
EDGAR
” means the Commission’s Electronic Data Gathering, Analysis and Retrieval System.
“
Effective Date
” shall mean each date and time that the Registration Statement, any post-effective amendment or amendments
thereto and any Rule 462(b) Registration Statement became or become effective.
“
Execution Time
” shall mean the
date and time that this Agreement is executed and delivered by the parties hereto.
“
FCPA
” means the Foreign Corrupt
Practices Act of 1977, as amended, and the rules and regulations thereunder.
“
FINRA
” means the Financial Industry
Regulatory Authority, Inc. or the National Association of Securities Dealers, Inc., or both, as the context shall require.
“
GAAP
” means generally accepted accounting principles in the United States.
“
General Disclosure Package
” shall mean the Preliminary Prospectus that is generally distributed to investors and used to
offer the Securities, and the information set forth in Exhibit B.
“
Lien
” means any security interest, mortgage,
pledge, lien, encumbrance, claim or equity.
“
Lock-Up Period
” means the period beginning on and including the date of
this Agreement through and including the date that is the 30th day after the date of this Agreement.
“
NYSE
” means
the New York Stock Exchange.
“
OFAC
” means the Office of Foreign Assets Control of the U.S. Treasury Department.
“
Organizational Documents
” means, when referring to the Company, the Company’s charter and by-laws or, when referring to
the Adviser or the Administrator, the Adviser’s or the Administrator’s respective certificates of formation and limited liability company agreements.
“
PCAOB
” means the Public Company Accounting Oversight Board (United States).
- 38 -
“
Pre-Pricing Prospectus
” means the Preliminary Prospectus dated
July 11, 2017 relating to the Securities in the form first furnished to the Underwriters for use in connection with the offering of the Securities.
“
Preliminary Prospectus
” means the preliminary prospectus supplement, dated as of July 11, 2017, together with
the Base Prospectus, in the form filed with the Commission pursuant to Rule 497 under the 1933 Act.
“
Prospectus
” means the prospectus supplement relating to the Securities, together with the Base Prospectus, filed by
the Company with the Commission pursuant to Rule 497 under the 1933 Act on or before the second business day after the date hereof (or such earlier time as may be required under the 1933 Act).
“
Registration Statement
” shall mean the registration statement referred to in paragraph 1(a)(i) above,
including exhibits and financial statements, as amended at the Execution Time (or, if not effective at the Execution Time, in the form in which it shall become effective) and, in the event any post-effective amendment thereto or any
Rule 462(b) Registration Statement becomes effective prior to the Closing Date, shall also mean such registration statement as so amended or such Rule 462(b) Registration Statement, as the case may be. Such term shall include any
Rule 430C Information deemed to be included therein at the Effective Date as provided by Rule 430C.
“
Regulation
S-T
” means Regulation S-T of the Commission.
“
Repayment Event
” means any event or condition which,
either immediately or with notice or passage of time or both, (i) gives the holder of any bond, note, debenture or other evidence of indebtedness (or any person acting on such holder’s behalf) the right to require the repurchase,
redemption or repayment of all or a portion of such indebtedness by the Company, or (ii) gives any counterparty (or any person acting on such counterparty’s behalf) under any swap agreement, hedging agreement or similar agreement or
instrument to which the Company is a party the right to liquidate or accelerate the payment obligations or designate an early termination date under such agreement or instrument, as the case may be.
“
RIC
” means a regulated investment company within the meaning of Section 851(a) of the Code.
“
Rule 172
,” “
Rule 173
,” “
Rule 405
,”
“
Rule 430C
,” “
Rule 433
” “
Rule 462(b)
” and “
Rule 497
” refer to such rules under the 1933 Act.
“
Rule 430C Information
” means the information included in the Prospectus or any amendment or supplement thereto
that was omitted from the Registration Statement at the time it became effective but that is deemed to be a part of the Registration Statement at the time it became effective pursuant to Rule 430C.
“
Rule 462(b) Registration Statement
” means a registration statement filed by the Company pursuant to
Rule 462(b) for the purpose of registering any of the Securities under the 1933 Act, including the documents and other information incorporated by reference therein and the Rule 430C Information.
- 39 -
“
Rule 482 Material
” means press releases or similar written
materials meeting the definition of an “advertisement” as set forth in Rule 482 under the 1933 Act, the use of which has been consented to by each of the Representatives.
“
Sales Material
” means advertising, sales literature or other promotional materials (including “prospectus
wrappers,” “broker kits,” “road show slides” and “road show scripts”), whether in printed or electronic form, authorized in writing by or prepared by the Company, the Adviser or the Administrator for use in
connection with the offering and sale of the Securities.
“
Sarbanes-Oxley Act
” means the Sarbanes-Oxley Act of
2002 and the rules and regulations promulgated thereunder or implementing the provisions thereof.
“
Subject
Instruments
” means all instruments, agreements and documents filed as exhibits to the Registration Statement pursuant to item 25.2 of Form N-2 of the Commission;
provided that
if any instrument, agreement or other document filed
as exhibits to the Registration Statement as aforesaid has been redacted or if any portion thereof has been deleted or is otherwise not included as part of such exhibit (whether pursuant to a request for confidential treatment or otherwise), the
term “Subject Instruments” shall nonetheless mean such instrument, agreement or other document, as the case may be, in its entirety, including any portions thereof which shall have been so redacted, deleted or otherwise not filed.
“
Testing-the-Waters Communication
” means any oral or written communication with potential investors
undertaken in reliance on Section 5(d) of the 1933 Act.
“
Written Testing-the-Waters
Communication
” means any Testing-the-Waters Communication that is a written communication within the meaning of Rule 405 under the 1933 Act.
All references in this Agreement to the Registration Statement, any Rule 462(b) Registration Statement, any Preliminary Prospectus,
the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the version thereof filed with the Commission pursuant to EDGAR and all versions thereof delivered (physically or electronically) to the Representatives
or the Underwriters.
SECTION 16.
Absence of Fiduciary Relationship.
The Company, the Adviser and the Administrator, severally
and jointly, acknowledge and agree that:
(a) each of the Underwriters is acting solely as an underwriter in connection with the sale of
the Securities and no fiduciary, advisory or agency relationship between the Company, the Adviser and the Administrator, on the one hand, and any of the Underwriters, on the other hand, has been created in respect of any of the transactions
contemplated by this Agreement, irrespective of whether or not any of the Underwriters has advised or is advising the Company, the Adviser or the Administrator on other matters;
(b) the public offering price of the Securities and the price to be paid by the Underwriters for the Securities set forth in this Agreement
were established by the Company, the Adviser and the Administrator following discussions and arms-length negotiations with the Representatives;
- 40 -
(c) it is capable of evaluating and understanding, and understands and accepts, the terms, risks
and conditions of the transactions contemplated by this Agreement;
(d) it is aware that the Underwriters and their respective affiliates
are engaged in a broad range of transactions which may involve interests that differ from those of the Company, the Adviser and the Administrator and that none of the Underwriters has any obligation to disclose such interests and transactions to the
Company, the Adviser or the Administrator by virtue of any fiduciary, advisory or agency relationship or otherwise; and
(e) it waives, to
the fullest extent permitted by law, any claims it may have against any of the Underwriters for breach of fiduciary duty or alleged breach of fiduciary duty and agrees that none of the Underwriters shall have any liability (whether direct or
indirect, in contract, tort or otherwise) to it in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on its behalf or in right of it or the Company, the Adviser or the Administrator or any stockholders,
employees or creditors of the Company, the Adviser or the Administrator.
SECTION 17.
Research Analyst Independence.
The
Company, the Adviser and the Administrator acknowledge that the Underwriters’ respective research analysts and research departments are required to be independent from their respective investment banking divisions and are subject to certain
regulations and internal policies, and that such Underwriters’ respective research analysts and research departments may hold views and make statements or investment recommendations and/or publish research reports with respect to the Company
and/or the offering that differ from the views of their respective investment banking divisions. The Company, the Adviser and the Administrator hereby waive and release, to the fullest extent permitted by applicable law, any claims that the Company,
the Adviser or the Administrator may have against the Underwriters with respect to any conflict of interest that may arise from the fact that the views expressed by their respective research analysts and research departments may be different from or
inconsistent with the views or advice communicated to the Company, the Adviser or the Administrator by such Underwriters’ respective investment banking divisions. The Company, the Adviser and the Administrator acknowledge that each of the
Underwriters is a full service securities firm and as such from time to time, subject to applicable securities laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity
securities of the Company and other entities that may be the subject of the transactions contemplated by this Agreement.
SECTION 18.
Trial By Jury.
The Company, the Adviser and the Administrator (each on its own behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and each of the Underwriters hereby irrevocably waives, to the
fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby.
SECTION 19.
Consent to Jurisdiction.
The Company, the Adviser and the Administrator hereby submit to the non-exclusive
jurisdiction of any U.S. federal or state court located in the Borough of Manhattan, the City and County of New York in any action, suit or proceeding arising out of or relating to or based upon this Agreement or any of the transactions contemplated
hereby, and irrevocably and unconditionally waive any objection to the laying of
- 41 -
venue of any such action, suit or proceeding in any such court and agree not to plead or claim in any such court that any such action, suit or proceeding has been brought in an inconvenient
forum.
[
Signature Pages Follow
]
- 42 -
If the foregoing is in accordance with your understanding of our agreement, please sign and
return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement among the Underwriters, the Company, the Adviser and the Administrator in accordance with its terms.
|
|
|
|
|
Very truly yours,
|
|
|
|
TRIPLEPOINT VENTURE GROWTH BDC CORP.
|
|
|
|
|
By
|
|
/s/ Sajal K. Srivastava
|
|
|
|
Name: Sajal K. Srivastava
|
|
|
|
Title: President
|
|
|
|
TPVG ADVISERS LLC
|
|
|
|
|
By
|
|
/s/ Sajal K. Srivastava
|
|
|
|
Name: Sajal K. Srivastava
|
|
|
|
Title: President
|
|
|
|
TPVG ADMINISTRATOR LLC
|
|
|
|
|
By
|
|
/s/ Sajal K. Srivastava
|
|
|
|
Name: Sajal K. Srivastava
|
|
|
|
Title: President
|
|
|
|
|
|
Accepted as of the date hereof:
|
|
|
|
KEEFE, BRUYETTE & WOODS, INC.
|
|
|
|
|
By:
|
|
/s/ Allen G. Laufenberg
|
|
|
|
Name: Allen G. Laufenberg
|
|
|
|
Title: Managing Director
|
|
|
|
MORGAN STANLEY & CO. LLC
|
|
|
|
|
By:
|
|
/s/ Yurij Slyz
|
|
|
|
Name: Yurij Slyz
|
|
|
|
Title: Executive Director
|
|
|
|
DEUTSCHE BANK SECURITIES INC.
|
|
|
|
|
By:
|
|
/s/ Patrick M. Käufer
|
|
|
|
Name: Patrick M. Käufer
|
|
|
|
Title: Managing Director
|
|
|
|
|
By:
|
|
/s/ Mary Hardgrove
|
|
|
|
Name: Mary Hardgrove
|
|
|
|
Title: Managing Director
|
For themselves and as Representatives of the other Underwriters named in Exhibit A hereto
EXHIBIT A
|
|
|
|
|
|
|
Underwriter
|
|
Aggregate Principal
Amount of Initial
Securities to be
Purchased
|
|
|
Keefe, Bruyette & Woods, Inc.
|
|
$
|
19,500,000
|
|
|
Morgan Stanley & Co. LLC
|
|
$
|
19,500,000
|
|
|
Deutsche Bank Securities Inc.
|
|
$
|
7,800,000
|
|
|
Janney Montgomery Scott LLC
|
|
$
|
6,500,000
|
|
|
BB&T Capital Markets, a division of BB&T Securities, LLC
|
|
$
|
6,500,000
|
|
|
Compass Point Research & Trading LLC
|
|
$
|
5,200,000
|
|
|
|
|
|
|
|
|
Total:
|
|
$
|
65,000,000
|
|
|
|
|
|
|
|
EXHIBIT B
PRICING TERM SHEET
July 11, 2017
$65,000,000
TriplePoint
Venture Growth BDC Corp.
2,600,000
5.75% NOTES DUE 2022
The following
sets forth the final terms of the 5.75% Notes due 2022 and should only be read together with the preliminary prospectus supplement dated July 11, 2017, together with the accompanying prospectus dated April 26, 2017, relating to these
securities (the “Preliminary Prospectus”), and supersedes the information in the Preliminary Prospectus to the extent inconsistent with the information in the Preliminary Prospectus. In all other respects, this pricing term sheet is
qualified in its entirety by reference to the Preliminary Prospectus. Terms used herein but not defined herein shall have the respective meanings as set forth in the Preliminary Prospectus. All references to dollar amounts are references to U.S.
dollars.
|
|
|
|
|
Issuer
|
|
TriplePoint Venture Growth BDC Corp.
|
|
|
|
|
Securities Offered
|
|
2,600,000 5.75% Notes due 2022 (the “Notes”)
|
|
|
|
|
Principal Amount
|
|
$65,000,000
|
|
|
|
|
Over-allotment Option
|
|
$9,750,000 principal amount
|
|
|
|
|
Maturity
|
|
July 15, 2022, unless earlier redeemed
|
|
|
|
|
Coupon
|
|
5.75%
|
|
|
|
|
Interest Payment Dates
|
|
January 15, April 15, July 15 and October 15, commencing October 15, 2017
|
|
|
|
|
Record Dates
|
|
January 1, April 1, July 1 and October 1, commencing October 1, 2017 (whether or not a Business Day), immediately preceding the relevant Interest Payment Date
|
|
|
|
|
Trade Date
|
|
July 11, 2017
|
|
|
|
|
Settlement Date
|
|
July 14, 2017 (DTC)
|
|
|
|
|
Public Offering Price
|
|
$25.00 per Note
|
|
|
|
|
Underwriters’ Purchase Price from Issuer
|
|
$24.25 per Note
|
|
|
|
|
Net Proceeds to the Issuer (before expenses)
|
|
$63,050,000 (assuming no exercise of the underwriters’ option to purchase additional Notes)
|
|
|
|
|
Denominations
|
|
$25 and integral multiples of $25 in excess thereof
|
|
|
|
|
Optional Redemption
|
|
The Notes may be redeemed in whole or in part at any time or from time to time at the Issuer’s option on or after July 15, 2019 upon not less than 30 days nor more than 60 days written notice by mail prior to the date
fixed for redemption thereof, at a redemption price of 100% of the outstanding principal amount of the Notes to be redeemed plus accrued and unpaid interest payments otherwise payable thereon for the then-current quarterly interest period accrued to
the date fixed for redemption. See “Description of the Notes—Optional Redemption”
|
|
|
|
|
|
Ratings
|
|
The Notes will not be rated by any nationally recognized statistical rating organization.
|
|
|
|
|
Listing
|
|
The Issuer intends to list the Notes on the New York Stock Exchange under the symbol “TPVY.” If approved for listing, trading on the New York Stock Exchange is expected to commence within 30 days after the Notes are first
issued.
|
|
|
|
|
CUSIP/ISIN
|
|
89677Y 308 / US89677Y3080
|
|
|
|
|
Use of Proceeds:
|
|
The Issuer intends to use the net proceeds from this offering to redeem all of its 6.75% fixed-rate notes due 2020 (the “2020 Notes”). As of July 10, 2017, the Issuer had outstanding 2020 Notes with an aggregate principal
amount of approximately $54.6 million plus accrued interest. If there are any remaining net proceeds after redeeming the 2020 Notes, the Issuer will use such remaining net proceeds to repay borrowings under its Credit Facility. As of July 10, 2017,
the Issuer had no borrowings outstanding under its Credit Facility. However, the Issuer intends to borrow approximately $20 million under its Credit Facility prior to the closing of this offering to make new investments in accordance with its
investment objective and strategies, and for general working capital purposes.
|
|
|
|
|
Joint Book-Running Managers
|
|
Keefe, Bruyette & Woods,
A Stifel Company
Morgan Stanley & Co. LLC
Deutsche Bank Securities
Inc.
|
|
|
|
|
Co-Lead Managers
|
|
BB&T Capital Markets, a division of BB&T Securities, LLC
Janney Montgomery Scott LLC
Compass Point Research & Trading
LLC
|
|
|
|
|
Certain Covenants
|
|
The indenture governing the Notes will include the covenants described under “Description of the Notes—Other Covenants” in the Preliminary Prospectus Supplement
|
This communication is intended for the sole use of the person to whom it is provided by us. This communication does not
constitute an offer to sell the Notes and is not soliciting an offer to buy the Notes in any jurisdiction where the offer or sale is not permitted.
TriplePoint Venture Growth BDC Corp. (“TriplePoint”) has filed a registration statement (including a prospectus) and a preliminary prospectus
supplement with the Securities and Exchange Commission (SEC) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement, the preliminary prospectus supplement and other
documents TriplePoint has filed with the SEC for more complete information about TriplePoint and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, TriplePoint, any underwriter or
any dealer participating in the offering will arrange to send you the prospectus and the preliminary prospectus supplement if you request it from any of the following investment banks: Keefe, Bruyette & Woods, Inc., Attention: Debt Capital
Markets, 787 Seventh Avenue, 4th Floor, New York, NY 10019, telephone (800) 966-1559; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, telephone (866) 718-1649; Deutsche
Bank Securities Inc., Attention: Prospectus Group, 60 Wall Street, New York, NY 10005, telephone (800) 503-4611.
EXHIBIT C
[Provided Supplementally]
EXHIBIT D
SUBSIDIARIES OF THE COMPANY
TPVG
Variable Funding Company LLC
TPVG Investment LLC
